CN101039587A - 糖果产品 - Google Patents
糖果产品 Download PDFInfo
- Publication number
- CN101039587A CN101039587A CNA2004800441742A CN200480044174A CN101039587A CN 101039587 A CN101039587 A CN 101039587A CN A2004800441742 A CNA2004800441742 A CN A2004800441742A CN 200480044174 A CN200480044174 A CN 200480044174A CN 101039587 A CN101039587 A CN 101039587A
- Authority
- CN
- China
- Prior art keywords
- confectionary products
- polymeric system
- mol
- plasticizer
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000009508 confectionery Nutrition 0.000 title abstract description 13
- 229920000642 polymer Polymers 0.000 claims abstract description 41
- 229920002689 polyvinyl acetate Polymers 0.000 claims abstract description 32
- 239000011118 polyvinyl acetate Substances 0.000 claims abstract description 32
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 27
- 239000003765 sweetening agent Substances 0.000 claims abstract description 27
- 239000004014 plasticizer Substances 0.000 claims description 46
- 235000013599 spices Nutrition 0.000 claims description 32
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 28
- 229920001971 elastomer Polymers 0.000 claims description 26
- 239000000806 elastomer Substances 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 25
- 239000000945 filler Substances 0.000 claims description 23
- 239000001087 glyceryl triacetate Substances 0.000 claims description 13
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 13
- 229960002622 triacetin Drugs 0.000 claims description 13
- 230000021736 acetylation Effects 0.000 claims description 12
- 238000006640 acetylation reaction Methods 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 7
- 125000005456 glyceride group Chemical group 0.000 claims description 5
- 239000008122 artificial sweetener Substances 0.000 claims description 4
- 235000021311 artificial sweeteners Nutrition 0.000 claims description 4
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 7
- 235000019634 flavors Nutrition 0.000 abstract description 7
- 239000000047 product Substances 0.000 description 108
- 239000000203 mixture Substances 0.000 description 34
- 239000003795 chemical substances by application Substances 0.000 description 28
- 239000001993 wax Substances 0.000 description 26
- 238000000576 coating method Methods 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- -1 phthalic acid ester Chemical class 0.000 description 23
- 239000000463 material Substances 0.000 description 22
- 150000001875 compounds Chemical class 0.000 description 21
- 235000015218 chewing gum Nutrition 0.000 description 19
- 229940112822 chewing gum Drugs 0.000 description 17
- 150000003839 salts Chemical class 0.000 description 17
- 235000019197 fats Nutrition 0.000 description 16
- 239000003814 drug Substances 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 239000011159 matrix material Substances 0.000 description 13
- 235000011187 glycerol Nutrition 0.000 description 12
- 238000002156 mixing Methods 0.000 description 12
- 230000003213 activating effect Effects 0.000 description 10
- 229920001577 copolymer Polymers 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 244000299461 Theobroma cacao Species 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 239000011777 magnesium Substances 0.000 description 9
- 229910052749 magnesium Inorganic materials 0.000 description 9
- 210000000214 mouth Anatomy 0.000 description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 9
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 150000001335 aliphatic alkanes Chemical class 0.000 description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 229960003260 chlorhexidine Drugs 0.000 description 8
- 229920002451 polyvinyl alcohol Polymers 0.000 description 8
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 8
- 229920002554 vinyl polymer Polymers 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 7
- 239000004902 Softening Agent Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 235000019219 chocolate Nutrition 0.000 description 7
- 230000002349 favourable effect Effects 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical group CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 6
- 230000001055 chewing effect Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000004040 coloring Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000003292 glue Substances 0.000 description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 230000010148 water-pollination Effects 0.000 description 6
- 239000000811 xylitol Substances 0.000 description 6
- 235000010447 xylitol Nutrition 0.000 description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 6
- 229960002675 xylitol Drugs 0.000 description 6
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 235000013569 fruit product Nutrition 0.000 description 5
- 239000000845 maltitol Substances 0.000 description 5
- 235000010449 maltitol Nutrition 0.000 description 5
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 229940083542 sodium Drugs 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical class ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 239000000899 Gutta-Percha Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 240000000342 Palaquium gutta Species 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229920002367 Polyisobutene Polymers 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 239000011149 active material Substances 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 229920005549 butyl rubber Polymers 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 4
- 208000002925 dental caries Diseases 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 229960001031 glucose Drugs 0.000 description 4
- 229920000588 gutta-percha Polymers 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000008123 high-intensity sweetener Substances 0.000 description 4
- 238000005984 hydrogenation reaction Methods 0.000 description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229960003088 loratadine Drugs 0.000 description 4
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 4
- 229910052750 molybdenum Inorganic materials 0.000 description 4
- 239000011733 molybdenum Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 229960002715 nicotine Drugs 0.000 description 4
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 4
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 230000005586 smoking cessation Effects 0.000 description 4
- 239000011775 sodium fluoride Substances 0.000 description 4
- 235000013024 sodium fluoride Nutrition 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 235000012222 talc Nutrition 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- JOROEVAWQLGPFQ-UHFFFAOYSA-N 1-benzhydryl-4-methylpiperazine;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.C1CN(C)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 JOROEVAWQLGPFQ-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 3
- NFLLKCVHYJRNRH-UHFFFAOYSA-N 8-chloro-1,3-dimethyl-7H-purine-2,6-dione 2-(diphenylmethyl)oxy-N,N-dimethylethanamine Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC(Cl)=N2.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 NFLLKCVHYJRNRH-UHFFFAOYSA-N 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 3
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 159000000013 aluminium salts Chemical class 0.000 description 3
- 229910000329 aluminium sulfate Inorganic materials 0.000 description 3
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 229960001803 cetirizine Drugs 0.000 description 3
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 3
- 229960000876 cinnarizine Drugs 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 229940099182 dramamine Drugs 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- GLVVKKSPKXTQRB-UHFFFAOYSA-N ethenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC=C GLVVKKSPKXTQRB-UHFFFAOYSA-N 0.000 description 3
- AFSIMBWBBOJPJG-UHFFFAOYSA-N ethenyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC=C AFSIMBWBBOJPJG-UHFFFAOYSA-N 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229940091249 fluoride supplement Drugs 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- 229940063647 marezine Drugs 0.000 description 3
- FJQXCDYVZAHXNS-UHFFFAOYSA-N methadone hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 FJQXCDYVZAHXNS-UHFFFAOYSA-N 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 229960002509 miconazole Drugs 0.000 description 3
- 229920003052 natural elastomer Polymers 0.000 description 3
- 229920001194 natural rubber Polymers 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000003605 opacifier Substances 0.000 description 3
- 229960005489 paracetamol Drugs 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229960003908 pseudoephedrine Drugs 0.000 description 3
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 3
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 3
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 3
- 229960002799 stannous fluoride Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 229960003708 sumatriptan Drugs 0.000 description 3
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 description 3
- 229920003051 synthetic elastomer Polymers 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- IHLKQCODTQXANL-UHFFFAOYSA-O 1-[10-(4-amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine;chloride Chemical compound [Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 IHLKQCODTQXANL-UHFFFAOYSA-O 0.000 description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 2
- IYOLBFFHPZOQGW-UHFFFAOYSA-N 2,4-dichloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=C(Cl)C(C)=C1Cl IYOLBFFHPZOQGW-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 2
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 2
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 2
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- FAEKWTJYAYMJKF-QHCPKHFHSA-N GlucoNorm Chemical compound C1=C(C(O)=O)C(OCC)=CC(CC(=O)N[C@@H](CC(C)C)C=2C(=CC=CC=2)N2CCCCC2)=C1 FAEKWTJYAYMJKF-QHCPKHFHSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- VHOQXEIFYTTXJU-UHFFFAOYSA-N Isobutylene-isoprene copolymer Chemical compound CC(C)=C.CC(=C)C=C VHOQXEIFYTTXJU-UHFFFAOYSA-N 0.000 description 2
- ALFGKMXHOUSVAD-UHFFFAOYSA-N Ketobemidone Chemical compound C=1C=CC(O)=CC=1C1(C(=O)CC)CCN(C)CC1 ALFGKMXHOUSVAD-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 2
- 229960004150 aciclovir Drugs 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229940037003 alum Drugs 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
- 229960003942 amphotericin b Drugs 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 150000004283 biguanides Chemical class 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 229960001736 buprenorphine Drugs 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- KVUAALJSMIVURS-ZEDZUCNESA-L calcium folinate Chemical compound [Ca+2].C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 KVUAALJSMIVURS-ZEDZUCNESA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960003291 chlorphenamine Drugs 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229960001380 cimetidine Drugs 0.000 description 2
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 150000001896 cresols Chemical class 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- YNKFCNRZZPFMEX-XHPDKPNGSA-N desmopressin acetate trihydrate Chemical compound O.O.O.CC(O)=O.C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 YNKFCNRZZPFMEX-XHPDKPNGSA-N 0.000 description 2
- 229950010569 dichloroxylenol Drugs 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- 229960000520 diphenhydramine Drugs 0.000 description 2
- AUZONCFQVSMFAP-UHFFFAOYSA-N disulfiram Chemical compound CCN(CC)C(=S)SSC(=S)N(CC)CC AUZONCFQVSMFAP-UHFFFAOYSA-N 0.000 description 2
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 2
- 229960001253 domperidone Drugs 0.000 description 2
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229960002472 eletriptan Drugs 0.000 description 2
- OTLDLQZJRFYOJR-LJQANCHMSA-N eletriptan Chemical compound CN1CCC[C@@H]1CC1=CN=C2[C]1C=C(CCS(=O)(=O)C=1C=CC=CC=1)C=C2 OTLDLQZJRFYOJR-LJQANCHMSA-N 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229960004943 ergotamine Drugs 0.000 description 2
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229960001596 famotidine Drugs 0.000 description 2
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 2
- MDQRDWAGHRLBPA-UHFFFAOYSA-N fluoroamine Chemical compound FN MDQRDWAGHRLBPA-UHFFFAOYSA-N 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000008191 folinic acid Nutrition 0.000 description 2
- 239000011672 folinic acid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 2
- 229960004068 hexachlorophene Drugs 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229960003029 ketobemidone Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000011133 lead Substances 0.000 description 2
- 229960001691 leucovorin Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 150000004667 medium chain fatty acids Chemical class 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229960001797 methadone Drugs 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 229960004503 metoclopramide Drugs 0.000 description 2
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- RHFUXPCCELGMFC-UHFFFAOYSA-N n-(6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl)-n-phenylmethoxyacetamide Chemical compound OC1C(C)(C)OC2=CC=C(C#N)C=C2C1N(C(=O)C)OCC1=CC=CC=C1 RHFUXPCCELGMFC-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 229960005254 naratriptan Drugs 0.000 description 2
- UNHGSHHVDNGCFN-UHFFFAOYSA-N naratriptan Chemical compound C=12[CH]C(CCS(=O)(=O)NC)=CC=C2N=CC=1C1CCN(C)CC1 UNHGSHHVDNGCFN-UHFFFAOYSA-N 0.000 description 2
- 229920001206 natural gum Polymers 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 2
- 229960000395 phenylpropanolamine Drugs 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003712 propranolol Drugs 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229960002354 repaglinide Drugs 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 229960000581 salicylamide Drugs 0.000 description 2
- 229950000975 salicylanilide Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 235000015149 toffees Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
- 229960002117 triamcinolone acetonide Drugs 0.000 description 2
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000004246 zinc acetate Substances 0.000 description 2
- 235000013904 zinc acetate Nutrition 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- NKQJVOJUSQJZPX-QMMMGPOBSA-N (2S)-3-(3,4-dihydroxyphenyl)-2-(ethylamino)propanoic acid Chemical compound CCN[C@@H](Cc1ccc(O)c(O)c1)C(O)=O NKQJVOJUSQJZPX-QMMMGPOBSA-N 0.000 description 1
- FELGMEQIXOGIFQ-CYBMUJFWSA-N (3r)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-CYBMUJFWSA-N 0.000 description 1
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ULDHMXUKGWMISQ-VIFPVBQESA-N (S)-(+)-Carvone Natural products CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- DYXBSXBXZNSAPO-UHFFFAOYSA-M 1,1-dimethylpyrrolidin-1-ium;iodide Chemical compound [I-].C[N+]1(C)CCCC1 DYXBSXBXZNSAPO-UHFFFAOYSA-M 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- JCPGMXJLFWGRMZ-UHFFFAOYSA-N 1-(2-hydroxyphenyl)-3-phenylpropan-1-one Chemical compound OC1=CC=CC=C1C(=O)CCC1=CC=CC=C1 JCPGMXJLFWGRMZ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- IRPGOXJVTQTAAN-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanal Chemical compound FC(F)(F)C(F)(F)C=O IRPGOXJVTQTAAN-UHFFFAOYSA-N 0.000 description 1
- LOVYCUYJRWLTSU-UHFFFAOYSA-N 2-(3,4-dichlorophenoxy)-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC=C(Cl)C(Cl)=C1 LOVYCUYJRWLTSU-UHFFFAOYSA-N 0.000 description 1
- MBHXKZDTQCSVPM-JRQHNPQYSA-N 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-[[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(OCCO)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 MBHXKZDTQCSVPM-JRQHNPQYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 description 1
- NKQVYJRZBVRXRU-UHFFFAOYSA-N 2-methyl-2-(methylamino)propanenitrile Chemical compound CNC(C)(C)C#N NKQVYJRZBVRXRU-UHFFFAOYSA-N 0.000 description 1
- AIDLAEPHWROGFI-UHFFFAOYSA-N 2-methylbenzene-1,3-dicarboxylic acid Chemical compound CC1=C(C(O)=O)C=CC=C1C(O)=O AIDLAEPHWROGFI-UHFFFAOYSA-N 0.000 description 1
- MPPQGYCZBNURDG-UHFFFAOYSA-N 2-propionyl-6-dimethylaminonaphthalene Chemical compound C1=C(N(C)C)C=CC2=CC(C(=O)CC)=CC=C21 MPPQGYCZBNURDG-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OQGYMIIFOSJQSF-UHFFFAOYSA-N 22205-05-6 Chemical compound Cl.C1C2=CC=C(O)C=C2C2(C)C(C)C1N(CC=C(C)C)CC2 OQGYMIIFOSJQSF-UHFFFAOYSA-N 0.000 description 1
- OWYLAEYXIQKAOL-UHFFFAOYSA-N 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone Chemical compound COC1=CC(OC)=CC(OC)=C1C(=O)CCCN1CCCC1 OWYLAEYXIQKAOL-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- WKEMJKQOLOHJLZ-UHFFFAOYSA-N Almogran Chemical compound C1=C2C(CCN(C)C)=CNC2=CC=C1CS(=O)(=O)N1CCCC1 WKEMJKQOLOHJLZ-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- KLZUFWVZNOTSEM-UHFFFAOYSA-K Aluminum fluoride Inorganic materials F[Al](F)F KLZUFWVZNOTSEM-UHFFFAOYSA-K 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- WMRRSVVFVYSOFY-UHFFFAOYSA-N C(CCC(=O)O)(=O)O.C(CCCCCCC)SCCCCCCCC Chemical compound C(CCC(=O)O)(=O)O.C(CCCCCCC)SCCCCCCCC WMRRSVVFVYSOFY-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- UDKCHVLMFQVBAA-UHFFFAOYSA-M Choline salicylate Chemical compound C[N+](C)(C)CCO.OC1=CC=CC=C1C([O-])=O UDKCHVLMFQVBAA-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 241000522215 Dipteryx odorata Species 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000360590 Erythrites Species 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 101000801619 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG1 Proteins 0.000 description 1
- LHFKHAVGGJJQFF-UEOYEZOQSA-N Hydroxy-alpha-sanshool Chemical compound C\C=C\C=C\C=C/CC\C=C\C(=O)NCC(C)(C)O LHFKHAVGGJJQFF-UEOYEZOQSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 1
- MQHWFIOJQSCFNM-UHFFFAOYSA-L Magnesium salicylate Chemical compound [Mg+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O MQHWFIOJQSCFNM-UHFFFAOYSA-L 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000002636 Manilkara bidentata Species 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- 241000276489 Merlangius merlangus Species 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- QZTLGJIUZACNEG-UHFFFAOYSA-N NCl.N1C=CC=C1 Chemical class NCl.N1C=CC=C1 QZTLGJIUZACNEG-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- ZSJRKTHYEVAUEN-UHFFFAOYSA-N OC1=CC=2C3(C)C(C)C(CC2C=C1)N(CC=C(C)C)CC3.C(C)(=O)O Chemical compound OC1=CC=2C3(C)C(C)C(CC2C=C1)N(CC=C(C)C)CC3.C(C)(=O)O ZSJRKTHYEVAUEN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241001495453 Parthenium argentatum Species 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- DOQPXTMNIUCOSY-UHFFFAOYSA-N [4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]-[2-(3,4-dimethoxyphenyl)ethyl]-methylazanium;chloride Chemical compound [H+].[Cl-].C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 DOQPXTMNIUCOSY-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 229960002133 almotriptan Drugs 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- UTUUIUQHGDRVPU-UHFFFAOYSA-K aluminum;2-aminoacetate;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Al+3].NCC([O-])=O UTUUIUQHGDRVPU-UHFFFAOYSA-K 0.000 description 1
- JIFPTBLGXRKRAO-UHFFFAOYSA-K aluminum;magnesium;hydroxide;sulfate Chemical compound [OH-].[Mg+2].[Al+3].[O-]S([O-])(=O)=O JIFPTBLGXRKRAO-UHFFFAOYSA-K 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 230000001062 anti-nausea Effects 0.000 description 1
- 229940124433 antimigraine drug Drugs 0.000 description 1
- 239000003420 antiserotonin agent Substances 0.000 description 1
- 229960004046 apomorphine Drugs 0.000 description 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960004754 astemizole Drugs 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 235000016302 balata Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000002333 black apple Nutrition 0.000 description 1
- OJGDCBLYJGHCIH-UHFFFAOYSA-N bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 description 1
- 229960003870 bromhexine Drugs 0.000 description 1
- 229960000725 brompheniramine Drugs 0.000 description 1
- ZDIGNSYAACHWNL-UHFFFAOYSA-N brompheniramine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 ZDIGNSYAACHWNL-UHFFFAOYSA-N 0.000 description 1
- 235000010634 bubble gum Nutrition 0.000 description 1
- 229960001705 buclizine Drugs 0.000 description 1
- MOYGZHXDRJNJEP-UHFFFAOYSA-N buclizine Chemical compound C1=CC(C(C)(C)C)=CC=C1CN1CCN(C(C=2C=CC=CC=2)C=2C=CC(Cl)=CC=2)CC1 MOYGZHXDRJNJEP-UHFFFAOYSA-N 0.000 description 1
- 229960001415 buflomedil Drugs 0.000 description 1
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 description 1
- 229960001058 bupropion Drugs 0.000 description 1
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical class C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 229960002688 choline salicylate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 1
- 229960005132 cisapride Drugs 0.000 description 1
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 229960001012 codeine hydrochloride Drugs 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000004567 concrete Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 229960001677 cyclizine hydrochloride Drugs 0.000 description 1
- UKPBEPCQTDRZSE-UHFFFAOYSA-N cyclizine hydrochloride Chemical compound Cl.C1CN(C)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 UKPBEPCQTDRZSE-UHFFFAOYSA-N 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 108700027018 deaminooxytocin Proteins 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- GTYWGUNQAMYZPF-QPLNMOKZSA-N demoxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 GTYWGUNQAMYZPF-QPLNMOKZSA-N 0.000 description 1
- 229960000477 demoxytocin Drugs 0.000 description 1
- 229940023487 dental product Drugs 0.000 description 1
- 229960004281 desmopressin Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229960001985 dextromethorphan Drugs 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229940031954 dibutyl sebacate Drugs 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- 229960001275 dimeticone Drugs 0.000 description 1
- HYPPXZBJBPSRLK-UHFFFAOYSA-N diphenoxylate Chemical compound C1CC(C(=O)OCC)(C=2C=CC=CC=2)CCN1CCC(C#N)(C=1C=CC=CC=1)C1=CC=CC=C1 HYPPXZBJBPSRLK-UHFFFAOYSA-N 0.000 description 1
- 229960004192 diphenoxylate Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960002563 disulfiram Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 229960005178 doxylamine Drugs 0.000 description 1
- HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 229950003246 ecabet Drugs 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960005450 eritrityl tetranitrate Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- SNFOERUNNSHUGP-ZXZARUISSA-N erythrityl tetranitrate Chemical compound [O-][N+](=O)OC[C@@H](O[N+]([O-])=O)[C@@H](O[N+]([O-])=O)CO[N+]([O-])=O SNFOERUNNSHUGP-ZXZARUISSA-N 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical compound C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 description 1
- 229960004770 esomeprazole Drugs 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- LUJQXGBDWAGQHS-UHFFFAOYSA-N ethenyl acetate;phthalic acid Chemical compound CC(=O)OC=C.OC(=O)C1=CC=CC=C1C(O)=O LUJQXGBDWAGQHS-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960004945 etoricoxib Drugs 0.000 description 1
- MNJVRJDLRVPLFE-UHFFFAOYSA-N etoricoxib Chemical compound C1=NC(C)=CC=C1C1=NC=C(Cl)C=C1C1=CC=C(S(C)(=O)=O)C=C1 MNJVRJDLRVPLFE-UHFFFAOYSA-N 0.000 description 1
- CAHCBJPUTCKATP-FAWZKKEFSA-N etorphine Chemical compound O([C@H]1[C@@]2(OC)C=C[C@@]34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O CAHCBJPUTCKATP-FAWZKKEFSA-N 0.000 description 1
- 229950004155 etorphine Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229940077441 fluorapatite Drugs 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000005089 fruit drop Effects 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229960001381 glipizide Drugs 0.000 description 1
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- MFWNKCLOYSRHCJ-BTTYYORXSA-N granisetron Chemical compound C1=CC=C2C(C(=O)N[C@H]3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-BTTYYORXSA-N 0.000 description 1
- 229960003727 granisetron Drugs 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 1
- 229960000930 hydroxyzine Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004164 isoxsuprine hydrochloride Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 229960003174 lansoprazole Drugs 0.000 description 1
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229960001508 levocetirizine Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229920003008 liquid latex Polymers 0.000 description 1
- 229960000994 lumiracoxib Drugs 0.000 description 1
- KHPKQFYUPIUARC-UHFFFAOYSA-N lumiracoxib Chemical compound OC(=O)CC1=CC(C)=CC=C1NC1=C(F)C=CC=C1Cl KHPKQFYUPIUARC-UHFFFAOYSA-N 0.000 description 1
- 229960004018 magaldrate Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 229940072082 magnesium salicylate Drugs 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229960004815 meprobamate Drugs 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229960005189 methadone hydrochloride Drugs 0.000 description 1
- WHLATLJVYMNVTJ-UHFFFAOYSA-N methyl n-(1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5h-benzo[a]heptalen-7-yl)carbamate Chemical compound C1=C(OC)C(=O)C=C2C(NC(=O)OC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 WHLATLJVYMNVTJ-UHFFFAOYSA-N 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 229960001110 miglitol Drugs 0.000 description 1
- 229940028441 minirin Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960003443 monoxerutin Drugs 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 229960004719 nandrolone Drugs 0.000 description 1
- NPAGDVCDWIYMMC-IZPLOLCNSA-N nandrolone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 NPAGDVCDWIYMMC-IZPLOLCNSA-N 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000000025 natural resin Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 229960004872 nizatidine Drugs 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960005343 ondansetron Drugs 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- VOKSWYLNZZRQPF-GDIGMMSISA-N pentazocine Chemical class C1C2=CC=C(O)C=C2[C@@]2(C)[C@@H](C)[C@@H]1N(CC=C(C)C)CC2 VOKSWYLNZZRQPF-GDIGMMSISA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- IZRPKIZLIFYYKR-UHFFFAOYSA-N phenyltoloxamine Chemical compound CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1 IZRPKIZLIFYYKR-UHFFFAOYSA-N 0.000 description 1
- 229960001526 phenyltoloxamine Drugs 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002744 polyvinyl acetate phthalate Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- 229960000425 rizatriptan Drugs 0.000 description 1
- TXHZXHICDBAVJW-UHFFFAOYSA-N rizatriptan Chemical compound C=1[C]2C(CCN(C)C)=CN=C2C=CC=1CN1C=NC=N1 TXHZXHICDBAVJW-UHFFFAOYSA-N 0.000 description 1
- 229960000371 rofecoxib Drugs 0.000 description 1
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 1
- 229960004586 rosiglitazone Drugs 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
- 229960004425 sibutramine Drugs 0.000 description 1
- 229960002639 sildenafil citrate Drugs 0.000 description 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- RCVIHORGZULVTN-YGJXXQMASA-M sodium;(1r,4as,10ar)-1,4a-dimethyl-7-propan-2-yl-6-sulfo-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate Chemical compound [Na+].OC(=O)[C@@](C)([C@@H]1CC2)CCC[C@]1(C)C1=C2C=C(C(C)C)C(S([O-])(=O)=O)=C1 RCVIHORGZULVTN-YGJXXQMASA-M 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- WOXKDUGGOYFFRN-IIBYNOLFSA-N tadalafil Chemical compound C1=C2OCOC2=CC([C@@H]2C3=C(C4=CC=CC=C4N3)C[C@H]3N2C(=O)CN(C3=O)C)=C1 WOXKDUGGOYFFRN-IIBYNOLFSA-N 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960002871 tenoxicam Drugs 0.000 description 1
- WZWYJBNHTWCXIM-UHFFFAOYSA-N tenoxicam Chemical compound O=C1C=2SC=CC=2S(=O)(=O)N(C)C1=C(O)NC1=CC=CC=N1 WZWYJBNHTWCXIM-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- YEZNLOUZAIOMLT-UHFFFAOYSA-N tolfenamic acid Chemical compound CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O YEZNLOUZAIOMLT-UHFFFAOYSA-N 0.000 description 1
- 229960002905 tolfenamic acid Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 229960003688 tropisetron Drugs 0.000 description 1
- UIVFDCIXTSJXBB-ITGUQSILSA-N tropisetron Chemical compound C1=CC=C[C]2C(C(=O)O[C@H]3C[C@H]4CC[C@@H](C3)N4C)=CN=C21 UIVFDCIXTSJXBB-ITGUQSILSA-N 0.000 description 1
- 229960002004 valdecoxib Drugs 0.000 description 1
- LNPDTQAFDNKSHK-UHFFFAOYSA-N valdecoxib Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=C(S(N)(=O)=O)C=C1 LNPDTQAFDNKSHK-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229960000881 verapamil hydrochloride Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229960001360 zolmitriptan Drugs 0.000 description 1
- UTAZCRNOSWWEFR-ZDUSSCGKSA-N zolmitriptan Chemical compound C=1[C]2C(CCN(C)C)=CN=C2C=CC=1C[C@H]1COC(=O)N1 UTAZCRNOSWWEFR-ZDUSSCGKSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/08—Chewing gum characterised by the composition containing organic or inorganic compounds of the chewing gum base
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/10—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
- A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Confectionery (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
本发明涉及一种包含聚合物体系、香料和甜味剂的糖果产品,至少约70wt%的所述聚合物体系包含聚乙酸乙烯酯(PVAc)并且少于10wt%的所述聚合物体系包含分子量(Mw)大于约50000g/mol的聚合物。
Description
技术领域
本发明涉及根据权利要求1的糖果产品。
背景技术
现有技术中公开了大量的各种口香糖。通常,这些口香糖的特征在于聚合物基物品,该聚合物基物品具有以弹性性能为特征的胶。为了获得所需的口香糖特性,通过考虑所应用的咀嚼成分而小心的使胶基形成所需尺寸从而保持这些弹性性能。
本发明的目的是提供具有太妃糖(toffee)类质地特性的糖果产品。
发明内容
本发明涉及一种包含聚合物体系、香料和甜味剂的糖果产品,至少约70wt%的所述聚合物体系包含聚乙酸乙烯酯(PVAc)并且少于10wt%的所述聚合物体系包含分子量(Mw)大于约50000g/mol的聚合物。
在本发明的实施方案中,所述糖果产品包含约5~约99wt%的聚合物体系、约0.001~约30wt%的香料和约5wt%~80wt%的甜味剂。
根据本发明,获得太妃糖类口香糖。该产品的骨架是聚合物体系,其功能基本等同于传统口香糖的胶基,虽然二者之间具有明显的质地差异。
此外,除了所得的质地特性之外,还获得了口香糖成分例如香料和甜味剂(有效成分)的改进的释放。
本发明的实施方案中,所述糖果产品包含含有可咀嚼聚合物体系的可咀嚼片。
根据本发明,可以评定该糖果产品具有与太妃糖相当的有利质地特性。因此,这种混合的糖果产品可以被制成所需尺寸,成为混合太妃糖口香糖产品。根据本发明的聚合物基糖果产品的太妃糖质地通过大量的聚乙酸乙烯酯和避免使用大量的高分子量聚合物特别是弹性体而获得。
在本发明的实施方案中,聚合物体系基本由聚乙酸乙烯酯单独形成。
具体地,只包含聚乙酸乙烯酯的聚合物体系是优选的,考虑到例如天然树脂倾向于,在本文中,削弱所需的太妃糖类特性。
在本发明的实施方案中,糖果产品包含少于4wt%的填料,优选少于1wt%。
根据本发明的优选实施方案,口香糖或聚合物体系中填料应该保持少量以保持糖果片的所需太妃糖类质地。
在本发明的实施方案中,糖果产品基本不含填料。
根据本发明的另外的优选实施方案,应该避免填料例如滑石,因为填料对糖果片的主要基于PVA的聚合物体系的影响可以削弱所需的太妃糖类质地。
在本发明的一个实施方案中,所述聚合物体系包含增塑剂。
根据本发明的实施方案,应用增塑剂的目的在于获得基于聚乙酸乙烯酯的聚合物体系的软咀嚼感。应该注意,所需的增塑很大程度上依赖于在产品中施用的其它成分。例如,一些侵略性的香料例如水果糖香料和酸与例如基于薄荷油的香料相比倾向于明显使聚合物体系软化。
具体地,根据本发明有用的增塑剂是三醋精、短链脂肪酸的乙酰化甘油一酸脂和甘油二酸脂以及甘油三酸脂、中链脂肪酸的乙酰化甘油一酸脂和甘油二酸脂以及甘油三酸脂、长链脂肪酸的乙酰化甘油一酸脂、松香的甲酯、低分子量PVAc。
优选实施方案中的优选增塑剂将具有对应于施用的PVAc的亲水性。
在本发明的实施方案中,所述聚合物体系包含少于30wt%的增塑剂,优选少于20wt%的增塑剂,最优选少于10wt%的增塑剂。
在本发明的实施方案中,糖果产品包含少于10wt%的增塑剂,优选少于8wt%的增塑剂,最优选少于4wt%的增塑剂。
根据本发明的优选实施方案,应该施用含量相对低的增塑剂,以获得所需的质地特性,即,太妃糖类咀嚼感。而且如果存在太多的增塑剂则可能出现异常特征,特别是当施用三醋精和甘油脂时。最后,增塑剂例如三醋精和乙酰化甘油酯昂贵并且量应该保持低。
在本发明的实施方案中,所述增塑剂包含三醋精。
在本发明的实施方案中,所述增塑剂包含乙酰化甘油酯。
在本发明的实施方案中,所述聚合物体系包含少于4wt%的分子量(Mw)为约50000~99999g/mol的聚合物。
在本发明的实施方案中,所述聚合物体系包含少于2wt%的分子量(Mw)为约100000~199999g/mol的聚合物。
在本发明的实施方案中,所述聚合物体系包含少于1wt%的分子量(Mw)为约200000~399999g/mol的聚合物。
在本发明的实施方案中,所述聚合物体系包含少于0.5wt%的分子量(Mw)为约399000~800000g/mol的聚合物。
在本发明的实施方案中,高分子量聚合物例如传统的弹性体或高分子量PVAc应该保持低浓度以获得所需的质地。
在本发明的实施方案中,所述聚合物体系基本不含弹性体。
在本发明的实施方案中,所述聚合物体系基本上单独包含聚乙酸乙烯酯(PVAc)。
根据本发明的优选实施方案,应该避免传统的弹性体,以避免典型的口香糖类弹性性质。根据本发明的最优选实施方案,产品的聚合物由聚乙酸乙烯酯组成。
显然,少量的其它聚合物在本发明的范围内是可接受的,而不损害本发明的原则,即PVAc单独提供太妃糖类质地。
在本发明的实施方案中,聚合物体系包含至少一种分子量(Mw)为约2000~40000g/mol的低分子量PVA、至少一种分子量(Mw)为40001~200000g/mol的高分子量PVA。
在本发明的实施方案中,聚合物体系包含至少一种分子量为约9000~30000g/mol、优选约13000~21000g/mol的低分子量(Mw)PVA。
在本发明的实施方案中,糖果产品包含至少一种分子量(Mw)为约2000~40000g/mol的低分子量PVA,其含量为聚合物体系的约70~99wt%。
在本发明的实施方案中,糖果产品包含至少一种分子量(Mw)为约40000~100000的高分子量PVA,其含量为聚合物体系的约0.5~10wt%。
在本发明的实施方案中,所述香料基本包含基于油的香料。
根据本发明的实施方案,当基本基于油的香料倾向于与聚合物体系相匹配时,优选这种基本基于油的香料,根据本发明其被认为是亲水性的。
根据本发明的又一实施方案,基本亲水的香料被证实是有利的,例如在延长释放方面。
在本发明的实施方案中,所述甜味剂包含糖。在本发明的实施方案中,所述甜味剂包含人造甜味剂。
根据本发明的优选实施方案,人造甜味剂可以有利地应用于太妃糖胶类糖果产品中。
在本发明的实施方案中,糖果产品的重量约1/4克~约10克,优选为约1/2克~约5克。
在本发明的实施方案中,糖果产品包含包衣。
根据本发明的糖果产品适合于本领域内几乎所有的包衣方法,例如硬包衣、膜包衣、软包衣等。
在本发明的又一有利的实施方案中,可以涂覆几层包衣并且所述层可以包含不同类型的层物质或由不同类型的层物质组成。
在本发明的有利实施方案中,巧克力可用作包衣,作为聚合物体系的产品模块(product module)或中心填充物被证实为对通常倾向于溶解传统口香糖配方的这种非常具有侵略性的增塑成分而言是稳定的。
根据本发明,糖果产品包含约0~约75wt%的涂覆在糖果产品芯上的外包衣。适当的包衣类型包括任意组成的硬包衣、膜包衣和软包衣,所述任意组分包括常用于口香糖、药物产品和糖果的包衣中那些组分。
根据本发明的优选实施方案,膜包衣被应用于糖果产品。
当前,一种优选的外包衣类型是硬包衣,该术语以其传统意义来使用,包括糖包衣和无糖包衣以及它们的组合。硬包衣的目的是获得消费者所偏好的甜的松脆层以及由于各种原因保护糖果产品芯。在为糖果产品芯提供保护性糖包衣的典型工艺中,在适当的包衣设备中利用可结晶糖例如蔗糖或葡萄糖的水溶液来连续处理糖果产品芯,根据所达到的包衣阶段,所述水溶液可以包含其它功能性成分,例如填料、颜料等。在本发明中,糖包衣可进一步含有功能性或活性化合物,包括香料化合物、药物活性化合物和/或聚合物降解物质。
然而,在糖果产品的生产中,可优选通过没有生龋作用的其他优选可结晶的甜味化合物来替代包衣中的生龋糖化合物。在本领域中,这种包衣通常被称为无糖包衣。目前,优选的非生龋硬包衣物质包括多元醇,例如通过工业方法分别氢化D-葡萄糖、麦芽糖、果糖或左旋糖、木糖、赤藓糖、乳糖、异麦芽酮糖和D-半乳糖而获得的山梨糖醇、麦芽糖醇、甘露醇、木糖醇、赤藓醇、乳糖醇、异麦芽酮糖醇和塔格糖。
在典型的硬包衣工艺中,如下文所详细说明,将含有可结晶糖和/或多元醇的糖浆涂覆到糖果产品芯上,并且通过利用热干燥空气鼓风蒸发掉它所含的水。这种循环必须重复几次,通常为10~80次,以达到所需的膨胀(swelling)。术语“膨胀”是指与开始相比在包衣操作结束时与开始相比并且相对于包衣产品的最终重量的产品重量的增加。根据本发明。包衣层例如构成最终糖果产品的约0~75wt%,例如约10~60wt%,包括约15~50wt%。
在又一个有用的实施方案中,本发明糖果产品单元(element)的外包衣是经历膜包衣工艺并且由此包含一种或多种成膜聚合物试剂和任选的一种或多种助剂例如增塑剂、色素和遮光剂的单元。膜包衣是涂覆到任意上述形式的糖果产品芯上的聚合物基薄包衣。这种包衣的厚度通常为20~100μm。通常,膜包衣通过下列过程而获得:使糖果产品芯穿过喷射适当的水或有机溶剂介质中的包衣材料的雾化液滴的喷雾区,接着干燥粘附在糖果产品芯上的材料,之后接受包衣的下一部分。重复该循环直到完成包衣。
在本文中,适当的膜包衣聚合物包括可食用纤维素衍生物,例如纤维素醚,包括甲基纤维素(MC)、羟乙基纤维素(HEC)、羟丙基纤维素(HPC)和羟丙基甲基纤维素(HPMC)。其它有用的膜包衣试剂是丙烯酸聚合物和共聚物,例如甲基丙烯酸酯氨基酯共聚物或纤维素衍生物和丙烯酸聚合物的混合物。特定组的膜包衣聚合物也被称为功能性聚合物,它们除了成膜特性之外还被赋予相对于糖果产品配方的活性成分的改进的释放性能。这种释放改进的聚合物包括甲基丙烯酸酯共聚物、乙基纤维素(EC)和肠溶性聚合物,这些物质被设计为抵抗酸性胃环境但是在十二指肠中容易溶解。后一组聚合物包括:醋酸邻苯二甲酸纤维素(CAP)、邻苯二甲酸聚醋酸乙烯酯(PVAP)、虫胶、甲基丙烯酸共聚物、乙酸偏苯三酸纤维素(CAT)和HPMC。应该理解的是,根据本发明的外膜包衣可以包含上述膜包衣聚合物的任意组合。
在其它实施方案中,根据本发明的糖果产品单元的膜包衣层包含增塑剂,该增塑剂能够改变聚合物的物理特性以使其在执行作为成膜材料的功能中更加有用。通常,增塑剂的作用是使得聚合物更柔软并且更加易弯曲,因为增塑剂分子将其本身插入各个聚合物束之间,由此阻断聚合物-聚合物的相互作用。在膜包衣中使用的大多数增塑剂是非晶形或具有非常小的结晶度。在本文中,适当的增塑剂包括多元醇例如丙三醇,乙二醇、聚乙二醇例如200~6000级的聚乙二醇、有机酯例如邻苯二甲酸酯、癸二酸二丁酯、柠檬酸酯和三醋精、油类/甘油酯包括蓖麻油、乙酰化甘油一酸酯和分馏的椰子油。
对本发明糖果产品的任选外包衣的成膜聚合物和增塑剂的选择基于如下考虑:就水分和气体溶解和扩散通过该膜而言,实现该包衣的最大可能的屏蔽性能。
糖果产品单元的膜包衣还可以包含一种或多种着色剂或遮光剂。除了提供所需的颜色之外,这些试剂可有助于保护糖果产品以避免咀嚼前的反应,特别是通过形成防水分和气体的屏障。适当的着色剂/遮光剂(pacifier)包括有机染料及其色淀、无机着色剂例如氧化钛以及天然颜料例如β-胡萝卜素。
另外,膜包衣可含有一种或几种助剂,例如香料和蜡或糖类化合物例如聚葡萄糖、糊精包括麦芽糊精、乳糖、改性淀粉、蛋白质例如明胶或玉米蛋白、植物胶以及它们的任意组合。
根据本发明的一方面,糖果产品的外包衣可含有一种或多种药物或化妆品成分,包括上文中所提及的那些。
因此,在其它实施方案中,本发明的上述硬包衣或膜包衣的糖果产品单元是这样一种单元:其中外包衣包含至少一种选自粘结剂、水分吸收成分、成膜剂、分散剂、防粘成分、填充剂、调味剂、着色剂、药物或化妆品活性成分、脂质成分、蜡成分、糖以及酸的添加剂成分。如果希望将外包衣中任意的这些添加剂成分的效果延迟到糖果产品的咀嚼,则根据本发明这些成分可以利用任意传统的胶囊剂来包封,所述胶囊剂例如包括明胶和大豆蛋白的蛋白质,包括上文所提及的任意的纤维素衍生物,淀粉衍生物、可食用合成聚合物和脂质,后者任选地为脂质体胶囊的形式。
在其它实施方案中,根据本发明的糖果产品单元提供有在现有技术中通常描述为软包衣形式的外包衣。这种软包衣可以利用传统方法来涂覆并且可有利地由糖或上述任意的非生龋、无糖甜味化合物以及淀粉水解物组成。
而且,应该注意的是,由于涂覆的阻挡层也起到完全或至少部分阻挡水分从环境转移到所述片中的作用,因此上述包衣是任选的或者它可以推迟直到它适合于制作工艺的最后部分。
在本发明的实施方案中,糖果产品可以形成为不同的形状,例如芯、椭圆体、球形、圆柱体、方形、矩形、六角形、条状、抛物面状、环形(donut formed)、环状(ring formed)和/或多模块(multi-modular)。同样,该产品可以是中心填充的。
在本发明的实施方案中,糖果产品包含活性成分。
适当的活性成分的实例如下所示。
在一个实施方案中,根据本发明的糖果产品包含药物、化妆品或生物活性物质。这种活性物质的实例例如在WO 00/25598中被全面列出,通过引用将其并入本文,包括药物、膳食补充剂、防腐剂、pH调节剂、戒烟剂和护理或治疗口腔和牙齿的物质例如过氧化氢以及在咀嚼时能够释放脲的化合物。防腐剂形式的有用活性物质的实例包括胍和双胍的盐及衍生物(例如,乙酸氯己定),以及具有有限水溶性的下述类型的物质:季铵化合物(例如神经酰胺(ceramine)、氯二甲酚、结晶紫、氯胺)、醛(如多聚甲醛)、特快灵(dequaline)化合物、polynoxyline、酚类(如麝香草酚、p-氯酚和甲酚)、六氯酚、水杨酸苯胺化合物、三氯生、卤素类(碘、碘消灵、氯胺、二氯氰尿酸盐)、醇类(3,4--二氯苯甲醇、苯甲醇、苯氧乙醇、苯乙醇),还参见Martindale,The Extra Pharmacopoeia,28th edition,page 547-~578;可以应当包括具有有限水溶性的金属盐、配位化合物和化合物,如铝盐(例如硫酸铝钾AlK(SO4)2,12H2O)和下列物质的盐、复配合物与化合物:硼、钡、锶、铁、钙、锌、(乙酸锌、氯化锌、葡萄糖酸锌)、铜(氯化铜、硫酸铜)、铅、银、镁、钠、钾、锂、钼、钒;护理口腔和牙齿的其它组分,例如含氟(如氟化钠、单氟磷酸钠、氨基氟化物、氟化亚锡)、磷酸盐、碳酸盐和硒的盐、配位化合物和化合物。其它活性物质可以在J.Dent.Res.Vol.28 No.2,page 160-171,1949中查到。
调节口腔中pH的试剂形式的活性物质的实例包括:酸,例如己二酸、丁二酸、延胡索酸或其盐,或柠檬酸、酒石酸、苹果酸、乙酸、乳酸、磷酸和戊二酸的盐,和可接受的碱,例如钠、钾、铵、镁或钙尤其是镁和钙的碳酸盐、碳酸氢盐、磷酸盐、硫酸盐或氧化物。
活性成分可以包含下面的化合物或其衍生物,但不限于此:对乙酰氨基酚、乙酰水杨酸、丁丙诺啡、溴己新、塞来昔布、可待因、苯海拉明、双氯芬酸、依托昔布、布洛芬、吲哚美辛、酮洛芬、氯美昔布、吗啡、奈普生、美沙酮、帕瑞昔布、吡罗昔康、伪麻黄碱、罗非昔布、替诺昔康、曲马多、戊地昔布、碳酸钙、氢氧化镁铝、二硫化四乙基萩兰姆、安非他酮、尼古丁、阿奇雷素、克拉霉素、克雷唑、红霉素、四环素、格拉司琼、恩丹西酮、异丙嗪(Prometazin)、托烷司琼、溴苯那敏、西替利嗪(Ceterizin)、左西替利嗪(leco-Ceterizin)、氯环嗪、氯苯那敏、氯苯那敏、Difenhydramine、多西拉敏、非诺非那定(Fenofenadin)、愈创甘油醚、氯雷他定、右氯雷他定(des-Loratidin)、苯托沙敏、异丙嗪、Pyridamine、特非那定、羟乙芦丁、甲基多巴、哌醋甲酯、苯孔氯铵、苄索氯铵、西吡氯铵、氯己定、依卡倍特钠、氟哌啶醇、别嘌醇、秋冰仙碱(Colchinine)、茶碱、普萘洛尔、强的松龙、强的松、氟化物、脲、爱妥糖(Actot)、格列本脲、格列吡嗪、甲福明、米格列醇、瑞格列奈(Repaglinide)、罗格列酮、阿朴吗啡、西力士(Cialis)、西地那非、瓦地那非、地芬诺酯、二甲硅油、西咪替丁、法莫替丁、雷尼替丁、Ratinidine、西替利嗪、氯雷他定、阿司匹林、苯佐卡因、右甲吗喃、苯丙醇胺、伪麻黄碱、西沙比利、多潘立酮、甲氧氯普胺、无环鸟苷(Acyclovir)、二辛基硫琥珀酸、酚酞、阿莫曲坦、依来曲普坦、麦角胺、托芬那酸(Migea)、那拉曲坦、雷扎曲坦、舒马曲坦(Sumatriptan)、佐米曲坦、铝盐、钙盐、亚铁盐、银盐、锌盐、两性霉素B、氯己定、咪康唑、曲安奈德、褪黑激素、苯巴比妥、咖啡因、苯二氮平、羟嗪、甲丙氨酯、吩噻嗪、布克利嗪、布洛他嗪、桂利嗪、赛克利嗪、Difenhydramine、茶苯海明、丁咯地尔、安非他明、咖啡因、麻黄碱、奥利司他、苯福林、苯丙醇胺、伪麻黄碱、西布曲明、酮康唑、硝酸甘油、制霉菌素、黄体酮、睾酮、维生素B12、维生素C、维生素A、维生素D、维生素E、毛果芸香碱、甘羟铝、西咪替丁、埃索美拉唑、法莫替丁、兰索拉唑、氧化镁、尼扎替丁和/或雷替尼丁。
本发明适合于活性剂的增加或加速释放,所述活性剂选自膳食补充剂、口腔或牙齿组合物、防腐剂、pH调节剂、戒烟剂、甜味剂、香料、芳香剂或药物。下面将对其中的一些进行说明。
根据本发明使用的活性剂可以是希望从糖果产品中释放的任何物质。希望以受控和/或加速速率释放的活性剂主要是具有有限水溶性的物质,通常低于10g/100ml,包括完全水溶性的物质在内。实例是药品、膳食补充剂、口腔组合物、戒烟剂、高效甜味剂、pH调节剂、调味剂等。
活性成分的其它实例包括扑热息痛、苯佐卡因、桂利嗪、薄荷醇、香芹酮、咖啡因、乙酸氯己定、盐酸赛克利嗪、1,8-桉油醇、南诺龙、咪康唑、Mystatine、氟化钠、尼古丁、西吡氯胺、其它季铵化合物、维生素E、维生素A、维生素D、格列苯脲或其衍生物、黄体酮、乙酰水杨酸、茶苯海明、赛克利嗪、甲硝唑、碳酸氢钠、银杏的活性组分、蜂胶的活性组分、人参的活性组分、美沙酮、薄荷油、水杨酰胺、氢化可的松或阿斯咪唑。
膳食补充剂形式的活性剂的实例例如是具有下列营养效果的盐和化合物:维生素B2(核黄素)、B12、亚叶酸、叶酸、烟酸、生物素、溶解性差的甘油磷酸酯、氨基酸、维生素A、D、E和K、含钙、磷、镁、铁、锌、铜、碘、锰、铬、硒、钼、钾、钠或钴的盐、配位化合物和化合物形式的矿物质。
此外,参考营养学家所列目录,该目录被不同国家的管理机构所接受,例如US code of Federal Regulations,Title 21,Section 182.5013.182 5997和182.8013-182.8997。
用于护理或治疗口腔和牙齿的化合物形式的活性剂实例例如是结合的过氧化氢以及能够在咀嚼过程中释放脲的化合物。
防腐剂形式的活性剂的实例有胍和双胍的盐与化合物(例如乙酸氯己定),以及下述类型的具有有限水溶性的物质:季铵化合物(例如ceramine、氯二甲酚、结晶紫、氯胺)、醛(如多聚甲醛)、特快灵(dequaline)衍生物、polynoxyline、酚类(如麝香草酚、p-氯酚和甲酚)、六氯酚、水杨酸苯胺化合物、三氯生、卤素类(碘、碘消灵、氯胺、二氯氰尿酸盐)、醇类(3,4-二氯苯甲醇、苯甲醇、苯氧乙醇、苯乙醇),还参见Martindale,TheExtra Pharmacopoeia,28th edition,page 547~578;应当包括具有有限水溶性的金属盐、配合物和化合物,如铝盐(例如硫酸铝钾AlK(SO4)2,12H2O)和下列物质的盐、配合物与化合物:硼、钡、锶、铁、钙、锌、(乙酸锌、氯化锌、葡萄糖酸锌)、铜(氯化铜、硫酸铜)、铅、银、镁、钠、钾、锂、钼、钒;护理口腔和牙齿的其它组分,例如含氟(如氟化钠、单氟磷酸钠、氨基氟化物、氟化亚锡)、磷酸盐、碳酸盐和硒的盐、配合物和化合物。
参考J.Dent.Res.Vol.28 No.2,pages 160-171,1949,其中提及了广泛的已试验化合物。
调节口腔中pH的试剂形式的活性剂的例子包括:如:可接受的酸,如己二酸、琥珀酸、延胡索酸或其盐,或柠檬酸、酒石酸、苹果酸、乙酸、乳酸、磷酸和戊二酸的盐;和可接受的碱,如钠、钾、铵、镁或钙尤其是镁和钙的碳酸盐、碳酸氢盐、磷酸盐、硫酸盐或氧化物。
戒烟剂形式的活性剂实例例如包括:尼古丁、烟草粉末或银盐,例如乙酸银、碳酸银和硝酸银。
在另一个实施方案中,蔗糖脂肪酸酯也可以用于增加甜味剂的释放,所述甜味剂包括例如所谓的高效甜味剂,例如糖精、环己烷氨基磺酸盐、阿斯巴甜、索马甜、二氢查耳酮、蛇菊苷、甘草甜或者它们的盐或化合物。对于甜味剂的增加释放来说,蔗糖脂肪酸酯优选具有至少40%,如至少50%的棕榈酸酯含量。
活性剂的其它实例是任意类型的药品。
药品形式的活性物质的实例包括咖啡因、水杨酸、水杨酰胺和相关物质(乙酰水杨酸、水杨酸胆碱、水杨酸镁、水杨酸钠)、扑热息痛、戊唑辛盐(盐酸戊唑辛和乙酸戊唑辛)、盐酸丁丙诺啡、盐酸可待因和磷酸可待因、吗啡和吗啡盐(盐酸盐、硫酸盐、酒石酸盐)、盐酸美沙酮、凯托米酮与凯托米酮的盐(盐酸盐)、β阻断剂(普萘洛尔)、钙拮抗剂、盐酸维拉帕米、硝苯地平,以及Pharm.Int.,Nov.85,pages 267~271,Barney H.Hunterand Robert L.Talbert中提到的合适的物质及其盐,硝酸甘油、丁四硝酯、马钱子碱及其盐、利多卡因、盐酸丁卡因、盐酸埃托啡、阿托品、胰岛素、酶(例如木瓜蛋白酶、胰蛋白酶、淀粉葡萄糖苷酶、葡萄糖氧化酶、链激酶、链道酶、葡聚糖酶、α-淀粉酶)、多肽(催产素、促性腺激素释放因子(LH.RH)、乙酸去氨加压素(DDAVP)、盐酸异克舒令、麦角胺化合物、氯喹(磷酸盐、硫酸盐)、异山梨酯、去氨缩宫素、肝素。
其它活性成分包括β-羽扇醇、Letigen、Sildenafil柠檬酸酯及其衍生物。
牙科产品包括尿素、CPP酪蛋白磷酸肽;氯己定;乙酸氯己定;盐酸氯己定、葡萄糖氯己定;Hexetedine、氯化锶、氯化钾、碳酸氢钠、碳酸钠、含氟成分、氟化物、氟化钠、氟化铝、氟化铵、氟化钙、氟化亚锡、其它含氟成分氟硅酸铵、氟硅酸钾、氟硅酸钠、单氟磷酸铵、单氟磷酸钙、单氟磷酸钾、单氟磷酸钠、油烯基(octadecentyl)氟化铵、硬脂基三羟乙基丙烯二胺二羟基氟化物。
维生素包括A、B1、B2、B6、B12、亚叶酸、叶酸、烟酸、泛酸(Pantothensyre)、生物素、C、D、E、K。矿物质包括钙、磷、镁、铁、锌、铜、Iod、锰、铬、硒、钼。其它的活性成分包括:Q10、酶。天然药物包括银杏、姜和鱼油。
本发明还涉及使用抗偏头痛药物,如5-羟色胺拮抗剂:舒马曲坦、佐米曲普坦、那拉曲坦、利扎曲普坦、依来曲普坦;抗恶心药物,如赛克利嗪、桂利嗪、茶苯海明、苯海拉明;抗花粉热药物,如西替利嗪、氯雷他定(Loratidin);疼痛缓解药物,如丁丙诺啡、曲马多;抗口腔疾病药物,如米康唑、两性霉素B、丙酮去炎松(Triamcinolonaceton);和药物Cisapid、多潘立酮、甲氧氯普胺。在优选的实施方案中,本发明涉及尼古丁及其盐的释放。
此外,本发明涉及制造根据权利要求1~66任一项的糖果产品的方法,由此通过分批式工艺来制造该产品。
公知的分批式制造方法是两步法,根据该方法,基于基本疏水的组分,在第一步中混合聚合物体系(在口香糖术语内被称为胶基),其中使其它亲水组分例如甜味剂等与聚合物体系一起混合。
此外,本发明涉及制造根据权利要求1~67中任一项的糖果产品的方法,由此通过挤出机工艺来制造该产品。
糖果产品和/或该产品的聚合物体系的制造可有利地通过挤出来实施。该工艺对于本发明非常具有吸引力并且有利,因为聚合物体系(胶基等同物)包含非常少的组分,例如优选三种组分:LMw、PVAc、HMw PVAc以及增塑剂例如三醋精。
详细说明
糖果产品组合物的概述
一般来说,根据本发明的糖果产品组合物通常包含水溶性本体部分、水不溶性可咀嚼聚合物体系部分和调味剂。水溶性部分在咀嚼过程中与部分调味剂一起消耗掉。聚合物体系部分在整个咀嚼过程中保留在口中。在一定程度上,聚合物体系在制造、成分以及一定程度的释放方面完全对应于传统的胶基。主要的差别在于聚合物体系的组成和质地特性。
聚合物体系组合物的概述
聚合物体系是根据本发明糖果产品的咀嚼物,其赋予最终产品以咀嚼特性。聚合物体系通常限定香料和甜味剂的释放特征,并且在最终产品中起到关键的作用。
糖果产品的不溶性部分通常可含有PVAc、增塑剂、蜡、软化剂、填料和其它任选成分例如着色剂和抗氧化剂的任意组合。其它的弹性体或高分子量PVAc可以以非常有限的程度应用于聚合物体系中而不损害所需的太妃糖类质地。
聚合物体系配方的组成可以基本上根据待制备的特定产品和根据最终产品的所需咀嚼以及其它感觉特征而变化。
聚合物体系成分的概述
弹性体的功能
根据本发明,弹性体特别是高分子量弹性体的量应该保持非常低,或者优选完全没有。根据优选实施方案,聚合物体系和最终的糖果产品应该基本不含弹性体。但是,当使用时,例如为了使聚合物体系稳定,弹性体可以为糖果产品提供弹性、粘结特性,这根据这种成分的化学结构以及它如何与其它成分结合而变化。适合用于本发明聚合物体系中的弹性体可包括天然或合成的弹性体。
弹性体可以是本领域中已知的任意水不溶性聚合物,并且包括在Food and Drug Administration,CFR,Title 21,Section 172,615,as“Masticatory Substances of Natural Vegetable Origin”和“MasticatorySubstances,Synthetic”中所列出的用于口香糖和泡泡糖的那些聚合物。
可用的天然弹性体包括天然橡胶例如发烟或液态胶乳以及银胶菊、天然树胶例如节路顿胶、lechi caspi、perillo、香豆乳胶、二齿铁线子胶、巧克力铁线子、糖胶树胶(nispero)、山榄胶、奇可树胶、杜仲胶、古塔胶、尼日尔杜仲胶、卡斯德拉胶、托帕匡斯麻风树、糖胶树胶(chiquibul)、古塔胶(gutta hang kang)。
可用的合成弹性体包括高分子弹性体例如丁二烯-苯乙烯共聚物、聚异丁二烯和异丁烯-异戊二烯共聚物,低分子量弹性体例如聚丁烯,聚丁二烯和聚异丁烯,乙烯基聚合物弹性体例如聚乙酸乙烯酯、聚乙烯,乙烯基共聚物弹性体例如乙酸乙烯酯/月桂酸乙烯酯、乙酸乙烯酯/硬脂酸乙烯酯、乙烯/乙酸乙烯酯、聚乙烯醇或其混合物。
丁二烯-苯乙烯类弹性体也可被称为SBR,其通常为约20∶80~60∶40的苯乙烯∶丁二烯单体的共聚物。当通过门尼粘度来评估时,这些单体的比率影响SBR的弹性。当苯乙烯∶丁二烯的比率减小时,门尼粘度降低。SBR的结构通常由与苯乙烯共聚合的直链1,3-丁二烯组成并且提供这些弹性体的非线型分子特性。SBR的平均分子量<600000g/mol。
异丁烯-异戊二烯类弹性体也可被称为丁基橡胶,其具有的异戊二烯的摩尔百分比水平为0.2~4.0。与SBR类似,当异戊二烯∶异丁烯的比率减小时,通过门尼粘度测量的弹性也降低。
丁基橡胶的结构通常由与支化2-甲基丙烯(异丁烯)共聚合的支化2-甲基-1,3-丁二烯(异戊二烯)组成,同SBR一样,这种结构实际上是非线型的,SBR的平均分子量为150000g/mol~1000000g/mol。
聚异丁烯也可被称为PIB,这类弹性体是2-甲基丙烯的聚合物,并且同SBR和丁基橡胶一样,其实际上是非线型的。低分子量弹性体为聚合物体系提供软咀嚼特性并且还如其它弹性体一样提供弹性性质。平均分子量可以为约30000~120000g/mol并且可以渗透约4毫米~20毫米。渗透程度越高,PIB越软。与SBR和丁基橡胶类似,高分子量弹性体为胶提供弹性。平均分子量可以为120000~1000000g/mol。如果使用的话,分子量应该相对低。
乙烯基聚合物的功能
根据本发明的聚合物体系的主成分是乙烯基聚合物。
乙烯基聚合物和共聚物型弹性体提供抗粘性、使由这些具有乙烯基聚合物的基体制成的产品的咀嚼特性变化并且提供有益于最终糖果产品的感官知觉的亲水特性。
对于乙烯基聚合物型弹性体,在月桂酸乙烯酯/乙酸乙烯酯(VL/VA)、硬脂酸乙烯酯/乙酸乙烯酯(VS/VA)或乙烯/乙酸乙烯酯(EVA)共聚物中的月桂酸乙烯酯、硬脂酸乙烯酯或乙烯的量通常分别为共聚物的约10~约60wt%。这些聚合物的平均分子量可以为约2000g/mol~约100000g/mol。
乙烯基聚合物例如聚乙烯醇和聚乙酸乙烯酯具有约8000g/mol~约65000g/mol的平均分子量。
增塑剂的功能
弹性体增塑剂使聚合物体系的稳定性不同。当用于聚合物体系中时,它们对聚合物分子间链断裂(增塑)的特异性以及它们不同的软化点引起最终糖果产品稳定性以及相容性的变化。
根据本发明的特别有用的增塑剂为三醋精、短链脂肪酸的乙酰化甘油一酸脂和甘油二酸脂以及甘油三酸脂、中链脂肪酸的乙酰化甘油一酸脂和甘油二酸脂以及甘油三酸脂、长链脂肪酸的乙酰化甘油一酸脂、松香的甲酯、低分子量PVAc。
使用的增塑剂可以是一种或者是多种的组合。通常,一种增塑剂与其它的之比取决于每一种增塑剂的软化点、对香料释放的影响以及它们所引起的胶的粘度。
蜡的功能
石油蜡有助于由聚合物体系制成的最终糖果产品的固化以及改进保存期限和质地。蜡晶体尺寸影响香料的释放。那些异烷烃含量高的蜡的晶体尺寸小于正烷烃含量高的蜡,特别是含有碳原子数小于30的正烷烃的那些。较小的晶体尺寸允许香料较慢释放,因为与具有较大晶体尺寸的蜡相比,其更加阻止香料从蜡中释放。与利用异烷烃蜡制成的聚合物体系相比,利用正烷烃蜡制成的聚合物体系的相容性较小。
蜡的列举
石油蜡(精炼石蜡和微晶蜡)和石蜡主要由直链正烷烃和支链异烷烃构成。正烷烃与异烷烃之比各异。
正烷烃蜡通常具有>C-18的碳链长度但是长度大多数不超过C-30。对于主要是正烷烃的那些蜡,支化和环结构靠近链的末端。正烷烃的粘度<10mm2/s(在100℃下),组合后的数均分子量<600g/mol。
异烷烃蜡通常具有大多数大于C-30的碳链长度。在主要是异烷烃的那些蜡中,支链和环结构随机沿碳链分布。异烷烃蜡的粘度大于10mm2/s(在100℃下),组合后的数均分子量>600g/mol。
通常很少通过石油蜡生产来生产合成蜡,因此不考虑石油蜡。合成蜡可以包括含有支化烷烃且与单体例如但不限于丙烯共聚合的蜡,和聚乙烯以及Fischer Tropsch型蜡。聚乙烯蜡是含有长度不同并且粘附有乙烯单体的烷烃单元的合成蜡。
天然蜡可以包括米糠蜡、蜂蜡、巴西棕榈蜡或小烛树蜡。
蜡可以单独使用或者可以任意组合使用。
软化剂的功能
软化剂的选择对基体的柔软性有影响。软化剂改进质地,导致基体的疏水性和亲水性组分混溶,并且还可以使聚合物体系的合成聚合物增塑。属于软化剂类的乳化剂为聚合物体系提供水结合特性,这赋予聚合物体系以令人愉悦的光滑表面并且减少它的粘结性。
适合用于聚合物体系中的软化剂除这些乳化剂之外还包括非氢化、部分氢化和完全氢化的植物油和动物脂、可可脂和脱脂可可粉的甘油三酸酯。
甘油三酸酯类包括棉籽、棕榈、棕榈仁、椰子、红花、油菜籽、向日葵、动物脂、大豆、可可脂、中链甘油三酸酯等。
甘油三酸酯的己酸、辛酸、癸酸、肉豆蔻酸、月桂酸和棕榈酸脂肪酸倾向于比主要含有硬脂酸脂肪酸的甘油三酸酯更加使合成弹性体增塑。
甘油一酸酯、甘油二酸酯、乙酰化甘油一酸酯和乙酰化甘油二酸酯、蒸馏的甘油一酸酯和甘油二酸酯、单硬脂酸甘油酯、单硬脂酸丙二醇酯、,Na、K、Mg和Ca的硬脂酸盐、三醋酸甘油酯、脂肪酸甘油一酸酯(例如硬脂酸、棕榈酸、油酸和亚油酸)、甘油一酸酯和甘油二酸酯的乳酸酯和乙酸酯、可食用脂肪酸的糖酯、卵磷脂和羟化卵磷脂属于乳化剂,它们中的大多数可含有少于2wt%的来自它们的制造加工的甘油三酸酯,其中所述可食用脂肪酸的糖酯也被称为蔗糖聚酯,所述蔗糖聚酯包括在WO 00/25598所公开的那些。
包括乳化剂的软化剂可以单独使用或者至少两种或更多种结合使用。
填料的功能
通常,根据本发明,最终糖果产品中填料的量应该保持低,优选完全不含填料,以保持所需的太妃糖类质地特性。
用于聚合物体系中的填料改进聚合物体系的质地并且有助于加工。颗粒尺寸对聚合物体系的粘结性、密度和加工特性及其混合有影响。颗粒尺寸越小,最终聚合物体系就越紧密且粘结性越强。而且,通过基于填料颗粒尺寸的分布来选择填料,可以改变初始物料的混合,因此允许在聚合物体系的处理过程中改变初始物料的混合特征以及最终改变由这些聚合物体系制成的胶的最终咀嚼特性。
适用于聚合物体系的填料包括碳酸镁和碳酸钙重质碳酸钙和硅酸盐类,例如硅酸镁和硅酸铝、高岭土和粘土、氧化铝、氧化硅、滑石以及氧化钛、磷酸一钙、磷酸二钙和磷酸三钙、硫酸钠、纤维素聚合物例如乙基、甲基纤维素和木材或其混合物。
滑石填料可用于本发明的聚合物体系以及糖果产品中,其可以接触或利用酸性香料或者提供防止人造甜味剂与碳酸钙类填料反应退化所需的酸性环境。碳酸钙和滑石填料的平均颗粒尺寸通常为约0.1微米~约15微米。
填料还可以包括天然有机纤维,例如水果蔬菜纤维、谷物、米、纤维素及其组合。
其它任选成分例如抗氧化剂、着色剂和香料的功能和列举
抗氧化剂延长聚合物体系、最终糖果产品或它们的相应组分包括脂肪和风味油的各个组分的保存期限和储存。适合用于聚合物体系中的抗氧化剂包括丁羟茴醚(BHA)、丁羟甲苯(BHT)、β-胡萝卜素、生育酚、酸化剂例如维生素C、没食子酸丙酯、其它合成和天然类型的抗氧化剂或其混合物。
香料和着色剂赋予特性或者去除或掩蔽所不希望的特性。着色剂通常可包括FD&C型色淀、植物提取物、水果和蔬菜提取物以及二氧化钛,香料通常可包括可可粉、热改性氨基酸以及其它蔬菜提取物。
聚合物体系的制备
通常将一定量的高分子量PVAc、低分子量PVAc和增塑剂加入到热的(10℃~120℃)的希格玛型浆式混合机来制备聚合物体系,所述混合机具有约1.2∶1~约2∶1的前后速度比,通常用于聚合物体系的速度比越高,则需要越激烈地混合它的中/高分子量的聚合物。
包含初始物料的成分的初始量可以通过混合釜的工作容量来确定,以获得适当稠度,并且通过所需的混合度以破坏即使是少量的中/高分子量聚合物并增加链的支化。混合的时间越长,使用越低分子量或软化点的聚合物体系成分,则最终聚合物体系的粘度和稳定性越低。
通常当成分聚集到一起时混合开始有效。混合时间的长可以为15~90分钟。
优选的是,混合时间为20分钟~约60分钟。
在初始成分已经均匀地聚集并且混合所需的时间之后,以连续的方式加入余量的聚合物体系成分,直到获得完全均匀的熔体。通常在初始混合时间之后的60分钟内加入所有剩余的聚合物体系组分。
典型的聚合物体系加工时间可以从约0.5到约4小时变化,优选为约0.5~1.5小时,这取决于配方。当卸料时最终物料温度可以为70℃~120℃,优选100℃~120℃。将完全熔体从混合釜中清空倒入有涂层或内衬的盘中,挤出并浇铸为任意所需形状并冷却和固化。本领域技术人员将理解,上述程序可以进行许多变化。
实施例1
根据本发明实施方案的聚合物体系通过对应于通常用于胶基混合方法的方法来制备。使用的方法涉及在Z浆式混合机中混合。聚合物体系包含下列组分:
95wt%的低分子量PVAc(15000g/mol Mw)
1wt%的高分子量PVAc(60000g/mol Mw)
4%的三醋精。
应该注意,聚合物体系的挤出可以有利地在本发明范围内应用。
实施例2
基于实施例1的聚合物体系来混合糖果产品。通过对应于通常用于混合胶基和亲水性口香糖组分的方法来实施混合。糖果产品包含:
0.3wt%的高甜度甜味剂
39wt%填充型甜味剂(木糖醇和山梨糖醇)
6wt%的麦芽糖醇糖浆
1.5wt%的酸
3.2wt%的柠檬香料
50wt%的实施例1的聚合物体系
由所产生的上述混合物形成具有椭圆形的形状和重约1.5g的糖果产品。
所得糖果产品外观类似于口香糖但是质地特性相当于太妃糖的质地。
甜味剂和香料的释放具有太妃糖类产品的特征并且与太妃糖类产品的一致性良好。
实施例3
基于实施例1的聚合物体系来混合糖果产品。通过对应于通常用于混合胶基和亲水性口香糖组分的方法来实施混合。糖果产品包含:
0.4wt%的高甜度甜味剂
3wt%的三醋精
43.6wt%填充型甜味剂(木糖醇和山梨糖醇)
6wt%的麦芽糖醇糖浆
7wt%的甘草香料
40wt%的实施例1的聚合物体系
由所产生的上述混合物形成具有椭圆形的形状和重约1.5g的糖果产品。
所得糖果产品外观类似于口香糖但是质地特性相当于太妃糖的质地。
甜味剂和香料的释放具有太妃糖类产品的特征并且与太妃糖类产品的一致性良好。还发现,与实施例2相比,该糖果产品需要稍多一些的增塑剂。这是因为柠檬香料和相关的酸倾向于用作具体使用的三醋精的重要辅助增塑剂。
实施例4
基于实施例1的聚合物体系来混合糖果产品。通过对应于通常用于混合胶基和亲水性口香糖组分的方法来实施混合。糖果产品包含:
0.4wt%的高甜度甜味剂
3wt%的三醋精
47.6wt%填充型甜味剂(木糖醇和山梨糖醇)
6wt%的麦芽糖醇糖浆
3wt%的巧克力/榛子香料
40wt%的实施例1的聚合物体系
由所产生的上述混合物形成具有椭圆形的形状和重约1.5g的糖果产品。
所得糖果产品外观类似于口香糖但是质地特性相当于太妃糖的质地。
甜味剂和香料的释放具有太妃糖类产品的特征并且与太妃糖类产品的一致性良好。还发现,由于与实施例3相同的原因,与实施例2相比,使用稍多一些的增塑剂是有利的。
实施例5
基于实施例1的聚合物体系来混合糖果产品。通过对应于通常用于混合胶基和亲水性口香糖组分的方法来实施混合。糖果产品包含:
0.4wt%的高甜度甜味剂
3wt%的三醋精
47.6wt%填充型甜味剂(木糖醇和山梨糖醇)
6wt%的麦芽糖醇糖浆
3wt%的薄荷香料
40wt%的实施例1的聚合物体系
由所产生的上述混合物形成具有椭圆形的形状和重约1.5g的糖果产品。
所得糖果产品外观类似于口香糖但是质地特性相当于太妃糖的质地。
甜味剂和香料的释放具有太妃糖类产品的特征并且与太妃糖类产品的一致性良好。还发现,由于与实施例3相同的原因,与实施例2相比,使用稍多一些的增塑剂是有利的。
实施例6
基于实施例1的聚合物体系来混合糖果产品。通过对应于通常用于混合胶基和亲水性口香糖组分的方法来实施混合。糖果产品包含:
59wt%的糖
6.3wt%葡萄糖糖浆
1.5wt%的酸
3.2wt%的柠檬香料
30wt%的实施例1的聚合物体系
由所产生的上述混合物形成具有椭圆形的形状和重约1.5g的糖果产品。
所得糖果产品外观类似于口香糖但是质地特性相当于太妃糖的质地。
甜味剂和香料的释放具有太妃糖类产品的特征并且与太妃糖类产品的一致性良好。
实施例7
利用包含木糖醇的硬包衣来包被实施例2~6的糖果产品。
实施例8
利用软包衣来包被实施例4和5的糖果产品。具体使用的软包衣是巧克力。应该注意,在本发明的范围内也可以使用其它的软包衣材料。
在本发明的有利实施方案中,巧克力被用作包衣,已经证实作为聚合物体系的产品模块或中心填充物对通常倾向于溶解传统口香糖配方的这种非常具有侵略性的增塑成分是稳定的。
通过评估,注意到,所需的太妃糖特征可以通过结合根据本发明的太妃糖类糖果产品和巧克力来有效地支持和/或改进。
在本发明范围内也可以应用其它的包衣层。应该注意,在本发明范围内糖果产品可以以多种不同的方式来制备,包括公知的两步法或例如挤出法。
而且还应该注意,形状、尺寸和重量可以根据产品的当前所需特性而明显变化。
因此,形状可以包括圆形、椭圆形、方形、多模块(multimodular),环形等。
一种特别的令人感兴趣的变化方案是中心填充的糖果结构。因此,已经证实,根据本发明使用的聚合物体系在咀嚼之前或之后都对基于脂肪的成分例如巧克力具有很好的抵抗性。
Claims (31)
1.一种糖果产品,其中包含
聚合物体系,
香料和
甜味剂,
其中至少约70wt%的所述聚合物体系包含聚乙酸乙烯酯(PVAc)并且少于10wt%的所述聚合物体系包含分子量(Mw)大于约50000g/mol的聚合物。
2.根据权利要求1的糖果产品,其中所述糖果产品包含:
约5wt%~约99wt%的聚合物体系,
约0.001wt%~约30wt%的香料和
约5wt%~约80wt%的甜味剂。
3.根据权利要求1或2的糖果产品,其中所述糖果产品包含含有可咀嚼聚合物体系的可咀嚼片。
4.根据权利要求1~3中任一项的糖果产品,其中所述聚合物体系基本由聚乙酸乙烯酯单独形成。
5.根据权利要求1~4中任一项的糖果产品,其中所述糖果产品包含少于4wt%的填料,优选少于1wt%。
6.根据权利要求1~5中任一项的糖果产品,其中所述糖果产品基本不含填料。
7.根据权利要求1~6中任一项的糖果产品,其中所述聚合物体系包含增塑剂。
8.根据权利要求1~7中任一项的糖果产品,其中所述聚合物体系包含少于30wt%的增塑剂,优选少于20wt%的增塑剂,最优选少于10wt%的增塑剂。
9.根据权利要求1~8中任一项的糖果产品,其中所述糖果产品包含少于10wt%的增塑剂,优选少于8wt%的增塑剂,最优选少于4wt%的增塑剂。
10.根据权利要求1~9中任一项的糖果产品,其中所述增塑剂包含三醋精。
11.根据权利要求1~10中任一项的糖果产品,其中所述增塑剂包含乙酰化甘油酯。
12.根据权利要求1~11中任一项的糖果产品,其中所述聚合物体系包含少于4wt%的分子量(Mw)为约50000~99999g/mol的聚合物。
13.根据权利要求1~12中任一项的糖果产品,其中所述聚合物体系包含少于2wt%的分子量(Mw)为约100000~199999g/mol的聚合物。
14.根据权利要求1~13中任一项的糖果产品,其中所述聚合物体系包含少于1wt%的分子量(Mw)为约200000~399999g/mol的聚合物。
15.根据权利要求1~14中任一项的糖果产品,其中所述聚合物体系包含少于0.5wt%的分子量(Mw)为约399000~800000g/mol的聚合物。
16.根据权利要求1~15中任一项的糖果产品,其中所述聚合物体系基本不含弹性体。
17.根据权利要求1~16中任一项的糖果产品,其中所述聚合物体系基本包含聚乙酸乙烯酯(PVAc)。
18.根据权利要求1~17中任一项的糖果产品,其中所述聚合物体系包含:
至少一种分子量(Mw)为约2000~40000g/mol的低分子量PVA,
至少一种分子量(Mw)为40001~200000g/mol的高分子量PVA。
19.根据权利要求1~18中任一项的糖果产品,其中所述聚合物体系包含至少一种分子量(Mw)为约9000~30000g/mol、优选约13000~21000g/mol的低分子量PVA。
20.根据权利要求1~19中任一项的糖果产品,其中包含分子量(Mw)为约2000~40000g/mol并且含量为所述聚合物体系的约70~99wt%的至少一种低分子量PVA。
21.根据权利要求1~20中任一项的糖果产品,其中包含分子量为约40000~100000g/mol并且含量为所述聚合物体系的约0.5~10wt%的至少一种高分子量PVA。
22.根据权利要求1~21中任一项的糖果产品,其中所述香料包含基本基于油的和/或基本亲水的香料。
23.根据权利要求1~22中任一项的糖果产品,其中所述甜味剂包含糖。
24.根据权利要求1~23中任一项的糖果产品,其中所述甜味剂包含人造甜味剂。
25.根据权利要求1~24中任一项的糖果产品,其中所述糖果产品可以形成为不同的形状,例如芯、椭圆体、球形、圆柱体、方形、矩形、六角形、条状、抛物面状、环形、环状、玩具熊状和/或多模块。
26.根据权利要求1~25中任一项的糖果产品,其中所述糖果产品重量约1/4克~约10克,优选为约1/2克~约5克。
27.根据权利要求1~26中任一项的糖果产品,其中所述糖果产品包含包衣。
28.根据权利要求1~27中任一项的糖果产品,其中所述糖果产品中心被填充。
29.根据权利要求1~28中任一项的糖果产品,其中所述糖果产品包含活性成分。
30.一种制造根据权利要求1~29中任一项的糖果产品的方法,其中通过分批式工艺来制造所述产品。
31.一种制造根据权利要求1~29中任一项的糖果产品的方法,其中通过挤出机工艺来制造所述产品。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/DK2004/000691 WO2006037319A1 (en) | 2004-10-08 | 2004-10-08 | Confectionery product |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101039587A true CN101039587A (zh) | 2007-09-19 |
CN101039587B CN101039587B (zh) | 2012-07-18 |
Family
ID=34958790
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2004800441742A Expired - Lifetime CN101039587B (zh) | 2004-10-08 | 2004-10-08 | 糖果产品 |
CN2005800342188A Expired - Fee Related CN101035436B (zh) | 2004-10-08 | 2005-05-20 | 包含巧克力的太妃糖胶 |
CN2005800342192A Active CN101035437B (zh) | 2004-10-08 | 2005-10-10 | 糖果产品 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800342188A Expired - Fee Related CN101035436B (zh) | 2004-10-08 | 2005-05-20 | 包含巧克力的太妃糖胶 |
CN2005800342192A Active CN101035437B (zh) | 2004-10-08 | 2005-10-10 | 糖果产品 |
Country Status (13)
Country | Link |
---|---|
US (8) | US9565867B2 (zh) |
EP (2) | EP1796482B2 (zh) |
JP (3) | JP2008515407A (zh) |
KR (3) | KR101279821B1 (zh) |
CN (3) | CN101039587B (zh) |
AT (1) | ATE515949T1 (zh) |
AU (2) | AU2004323874A1 (zh) |
CA (2) | CA2581289C (zh) |
DK (1) | DK1796484T3 (zh) |
ES (2) | ES2369501T5 (zh) |
MX (3) | MX2007004045A (zh) |
RU (2) | RU2364244C2 (zh) |
WO (2) | WO2006037319A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108289469A (zh) * | 2015-12-02 | 2018-07-17 | 日清奥利友集团株式会社 | 包覆用油脂组合物 |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006037343A1 (en) * | 2004-10-08 | 2006-04-13 | Gumlink A/S | Confectionery product |
US9565867B2 (en) | 2004-10-08 | 2017-02-14 | Gumlink A/S | Confectionery product comprising low molecular weight polyvinyl acetate |
JP5225077B2 (ja) * | 2005-05-23 | 2013-07-03 | クラフト・フーズ・グローバル・ブランズ・エルエルシー | 中心充填チューインガム組成物 |
US20080248174A1 (en) * | 2005-09-27 | 2008-10-09 | Angelo Martincich | Process for Obtaining a Soft White Milk-Based Coating and Coating So Obtained |
US20070237855A1 (en) | 2006-04-05 | 2007-10-11 | Cadbury Adams Usa Llc | Calcium phosphate complex in acid containing confectionery |
AU2007235359B2 (en) | 2006-04-05 | 2011-03-10 | Intercontinental Great Brands Llc | Calcium phosphate complex and salts in oral delivery systems |
WO2008037251A1 (en) * | 2006-09-29 | 2008-04-03 | Cadbury Holdings Limited | Chewing gum comprising polyethylene |
JP5225032B2 (ja) * | 2008-11-07 | 2013-07-03 | 日本クラフトフーズ株式会社 | チューインガム及びその製造方法 |
US20120027893A1 (en) * | 2009-03-30 | 2012-02-02 | Trident Seafoods Corporation | Viscous liquid dietary supplement for animals |
US20120015094A1 (en) | 2009-04-09 | 2012-01-19 | The Folgers Coffee Company | Ground roast coffee tablet |
EP2416665B1 (en) * | 2009-04-09 | 2017-01-04 | The Folger Coffee Company | Ground roast coffee tablet |
JP5732043B2 (ja) * | 2009-04-24 | 2015-06-10 | オムヤ インターナショナル アーゲー | 活性成分を放出制御するための粒状物質 |
US20130101706A1 (en) * | 2009-12-30 | 2013-04-25 | Andrea Haseleu | Hard and crunchy confectionary coating |
BR112012028657A2 (pt) * | 2010-05-10 | 2015-09-15 | Cargill Inc | composições de cacau em pó |
KR101155328B1 (ko) * | 2010-07-20 | 2012-06-19 | 롯데제과주식회사 | 카라멜이 들어있는 츄잉껌 |
JP2012100571A (ja) * | 2010-11-09 | 2012-05-31 | Ryugetsu Holdings:Kk | チョコレート被覆菓子の製造方法、チョコレート被覆菓子製造装置 |
KR101252968B1 (ko) * | 2011-06-13 | 2013-04-09 | 다사농업협동조합 | 쌀가루가 함유되는 마지팬 제조방법 |
US20150004281A1 (en) * | 2011-12-16 | 2015-01-01 | Wm. Wrigley Jr. Company | Low density chewing gum and method of making same |
CN102422965B (zh) * | 2011-12-28 | 2013-04-10 | 津市市中意糖果有限公司 | 一种富含花生蛋白的太妃糖及其生产方法 |
CN102754907B (zh) * | 2012-01-20 | 2015-06-24 | 奥驰亚客户服务公司 | 口腔用产品 |
RU2662283C2 (ru) | 2012-08-10 | 2018-07-25 | Вм. Ригли Джр. Компани | Основа жевательной резинки (варианты) |
JP6240431B2 (ja) * | 2012-09-04 | 2017-11-29 | クラシエフーズ株式会社 | 延伸性チューインガム及びチューインガム用延伸性付与剤 |
RU2507858C1 (ru) * | 2012-10-03 | 2014-02-27 | Российская Академия сельскохозяйственных наук Государственное научное учреждение научно-исследовательский институт кондитерской промышленности (ГНУ НИИКП) | Способ производства молочных конфет вязкотягучей консистенции |
CN103315288B (zh) * | 2013-03-25 | 2014-11-05 | 中国人民解放军总医院 | 可清洁口腔牙齿的高热量咀嚼片 |
JP6240430B2 (ja) * | 2013-08-07 | 2017-11-29 | クラシエフーズ株式会社 | 高延伸性チューインガム及びそれを用いた組合せチューインガム |
KR20150079282A (ko) * | 2013-12-31 | 2015-07-08 | 삼성정밀화학 주식회사 | 장용성 코팅 조성물, 장용성 코팅막 및 식품 제제 |
JP6359759B2 (ja) | 2014-06-30 | 2018-07-18 | インターコンチネンタル グレート ブランズ エルエルシー | コーティング中に高い濃度の液体香料を含有した着色コーティングされた食用製品、及びその製造方法 |
KR101494367B1 (ko) * | 2014-11-11 | 2015-03-02 | 주식회사 아우레이트 | 초콜릿과자 제조방법 및 이에 의해 제조된 초콜릿과자 |
USD796775S1 (en) | 2015-09-09 | 2017-09-12 | Intercontinental Great Brands Llc | Confection |
CN105341283A (zh) * | 2015-09-30 | 2016-02-24 | 郑州荣利达生物科技有限公司 | 一种太妃酱、含有太妃酱的蜂窝状糖、制备方法 |
US11612183B2 (en) * | 2015-12-10 | 2023-03-28 | R.J. Reynolds Tobacco Company | Protein-enriched tobacco composition |
AU2017206060A1 (en) | 2016-01-06 | 2018-07-19 | Benita KATZENELLENBOGEN | Novel compounds which activate estrogen receptors and compositions and methods of using the same |
US11497227B2 (en) | 2016-09-30 | 2022-11-15 | Wm. Wrigley Jr. Company | Chewy confection with reduced sugar |
US11234448B1 (en) | 2017-09-08 | 2022-02-01 | The Hershey Company | High water activity confectionery product and process of making same |
RU2687450C1 (ru) * | 2018-06-13 | 2019-05-13 | федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный университет" (КемГУ) | Способ производства белковых батончиков для питания спортсменов |
US10952460B2 (en) * | 2018-11-05 | 2021-03-23 | Blesst Boyz LLC | Composition for a tobacco-free chew and method of manufacturing same |
WO2021021626A1 (en) * | 2019-07-26 | 2021-02-04 | Wm. Wrigley Jr. Company | Polyol-containing chewing gum bases |
JP2023504756A (ja) | 2019-12-09 | 2023-02-06 | ニコベンチャーズ トレーディング リミテッド | カンナビノイドを含む口腔用製品 |
US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
US11889856B2 (en) | 2019-12-09 | 2024-02-06 | Nicoventures Trading Limited | Oral foam composition |
US11883527B2 (en) | 2019-12-09 | 2024-01-30 | Nicoventures Trading Limited | Oral composition and method of manufacture |
US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
US11672862B2 (en) | 2019-12-09 | 2023-06-13 | Nicoventures Trading Limited | Oral products with reduced irritation |
US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
US20210195929A1 (en) * | 2019-12-31 | 2021-07-01 | Kraft Foods Group Brands Llc | No sugar added multilayer edible products comprising a center and a barrier layer |
US20230165269A1 (en) * | 2020-05-04 | 2023-06-01 | Wm. Wrigley Jr. Company | Chewable matrix and use thereof for the collection of saliva samples and infection detection |
US11839602B2 (en) | 2020-11-25 | 2023-12-12 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
Family Cites Families (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US448452A (en) * | 1891-03-17 | Hand-vise | ||
GB111187A (en) | 1916-12-06 | 1917-11-22 | Arthur Illingworth Grabham | A Combined Fastener and Seal. |
US2700012A (en) | 1949-02-05 | 1955-01-18 | Wallace & Tiernan Company Inc | Manufacture of chewing gum for fluorine prophylaxis |
GB711187A (en) * | 1952-03-29 | 1954-06-23 | Edgar Victor Johnson | Improvements in or relating to chewing gum |
US2915024A (en) | 1954-05-03 | 1959-12-01 | Nat Biscuit Co | Process and machine for coating articles with chocolate or the like |
US3440060A (en) * | 1965-12-23 | 1969-04-22 | Union Carbide Corp | Chewing gums |
GB1183125A (en) | 1966-09-09 | 1970-03-04 | Werner Bahlsen | Improvements in or relating to Processes and Apparatus for Coating Articles with Chocolate |
JPS4823974B1 (zh) | 1970-02-27 | 1973-07-18 | ||
US3877468A (en) * | 1970-07-22 | 1975-04-15 | Leo Ab | Chewable tobacco substitute composition |
JPS4819950B1 (zh) | 1970-12-30 | 1973-06-18 | ||
US4032667A (en) | 1973-02-28 | 1977-06-28 | Kreucoha Ag | Method for coating confectionery articles with chocolate |
FR2231939B1 (zh) | 1973-06-01 | 1975-08-22 | France Etat | |
US4127677A (en) † | 1977-12-12 | 1978-11-28 | Life Savers, Inc. | Xylitol-coated chewing gum and method |
GB2018668B (en) | 1978-04-11 | 1982-03-24 | Baker Perkins Holdings Ltd | Producing centre-filled bars of confectionery |
US4224345A (en) * | 1978-10-16 | 1980-09-23 | Lotte Co., Ltd | Chewing gum base and a combination of a chewing gum with fatty matter |
DE2905979C2 (de) | 1979-02-16 | 1981-01-22 | Carl-Jacob Gatzen | Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen |
US4238510A (en) * | 1979-02-21 | 1980-12-09 | Life Savers, Inc. | Sugarless coating for chewing gum and confections and method |
DE2912412B1 (de) * | 1979-03-29 | 1980-10-02 | Storck August Gmbh | Umhuellte Suessware mit hohem Proteingehalt und ihre Herstellung |
JPS588819B2 (ja) | 1979-11-28 | 1983-02-17 | 株式会社 ロツテ | 改良風船ガムの製造方法 |
US4352824A (en) * | 1980-03-27 | 1982-10-05 | Nabisco Brands, Inc. | Chewing gum containing fatty or gelatinous sweetener and method |
JPS5712958A (en) | 1980-06-26 | 1982-01-22 | Lotte Co Ltd | Improved chocolate chewing gum |
US4357359A (en) | 1980-09-11 | 1982-11-02 | Cloud Corporation | Method and apparatus for manufacture of candy |
US4317837A (en) * | 1980-11-25 | 1982-03-02 | Life Savers, Inc. | Tobacco-flavored chewing gum |
US4352822A (en) | 1980-12-15 | 1982-10-05 | Nabisco Brands Inc. | Gum base, chewing gum containing same and method |
JPS57198050A (en) | 1981-05-30 | 1982-12-04 | Lotte Co Ltd | Bubble gum |
US4385071A (en) | 1981-08-10 | 1983-05-24 | Donna Yakimischak | Chewing gum flavor combination |
US4486452A (en) | 1981-11-04 | 1984-12-04 | Cloud Corporation | Method for manufacture of candy |
DE3235024A1 (de) | 1982-02-05 | 1983-08-11 | Robert Bosch Gmbh, 7000 Stuttgart | Verfahren und vorrichtung zum formen eines karamelmassestranges |
US4450179A (en) | 1982-06-25 | 1984-05-22 | Nabisco Brands, Inc. | Two component soft candy |
US4518615A (en) | 1983-08-23 | 1985-05-21 | Warner-Lambert Company | Non-adhesive chewing gum base composition |
JPS6083539A (ja) | 1983-10-08 | 1985-05-11 | Lotte Co Ltd | チヨコレ−トチユ−インガム |
US4624269A (en) * | 1984-09-17 | 1986-11-25 | The Pinkerton Tobacco Company | Chewable tobacco based product |
US4555407A (en) | 1984-12-24 | 1985-11-26 | General Foods Corporation | Continuous chewing gum method |
US4929447A (en) | 1986-01-07 | 1990-05-29 | Warner-Lambert Company | Encapsulation composition for use with chewing gum and edible products |
US4794003A (en) * | 1986-04-01 | 1988-12-27 | Warner-Lambert Company | Polyvinylacetate bubble gum base composition |
US4721620A (en) * | 1986-04-01 | 1988-01-26 | Warner-Lambert Company | Polyvinylacetate bubble gum base composition |
US4872884A (en) | 1986-12-10 | 1989-10-10 | Warner-Lambert Company | Reduced calorie chewing gum base and compositions containing the same |
US5023093A (en) | 1986-12-10 | 1991-06-11 | Warner-Lambert Company | Reduced calorie chewing gum base and compositions containing the same |
US4931293A (en) * | 1986-12-23 | 1990-06-05 | Warner-Lambert Company | Food acid delivery systems containing polyvinyl acetate |
US4816265A (en) | 1986-12-23 | 1989-03-28 | Warner-Lambert Company | Sweetener delivery systems containing polyvinyl acetate |
JPH0783679B2 (ja) | 1987-08-05 | 1995-09-13 | 三菱化学株式会社 | ファットブル−ム防止剤 |
US5125819A (en) | 1987-11-24 | 1992-06-30 | Warner-Lambert Company | Apparatus for making center-filled chewing gum |
US4889726B1 (en) * | 1988-09-02 | 1993-12-21 | Wm. Wrigley Jr. Company | Using cocoa powder to enhance the flavor of a mint flavored chewing gum |
US5035905A (en) | 1988-10-04 | 1991-07-30 | Warner-Lambert Company | Methods for forming a fold-over soft center-filled confection |
US5002791A (en) | 1988-10-28 | 1991-03-26 | Warner-Lambert Company | Process for forming a confectionary rope having a viscous center |
US5057328A (en) * | 1988-11-14 | 1991-10-15 | Warner-Lambert Company | Food acid delivery systems containing polyvinyl acetate |
US4933189A (en) | 1988-12-29 | 1990-06-12 | Warner-Lambert Company | Chewing gum having longer lasting sweetness |
US5110608A (en) | 1988-12-29 | 1992-05-05 | Warner-Lambert Company | Chewing gums having longer lasting sweetness |
US4968511A (en) | 1989-03-10 | 1990-11-06 | Amelia Ronald P D | Composition and process for one-step chewing gum |
US5279846A (en) | 1989-04-28 | 1994-01-18 | Asahi Denka Kogyo Kabushiki Kaisha | Chocolate composition |
DK365389D0 (da) * | 1989-07-24 | 1989-07-24 | Fertin Lab As | Antifungalt tyggegummipraeparat |
US5116626A (en) * | 1991-07-25 | 1992-05-26 | Wm. Wrigley Jr. Company | Transparent base and gum composition |
US5358729A (en) * | 1991-08-28 | 1994-10-25 | Matsutani Chemical Industries Co., Ltd. | Indigestible dextrin |
US5173317A (en) * | 1991-10-29 | 1992-12-22 | Wm. Wrigley Jr. Company | Gum compositions containing vinyl laurate/vinyl acetate copolymer |
CH682723A5 (it) | 1992-01-21 | 1993-11-15 | Soremartec Sa | Procedimento per applicare rivestimenti alimentari a partire da sostanze alimentari scorrevoli, ad esempio a base di cioccolato, con temperaggio dello stesso, e relativo dispositivo. |
US5364653A (en) * | 1992-12-03 | 1994-11-15 | Nakayama Raymond M | Fruit and nut-containing confectionary candy and method of preparation |
FR2706737B1 (zh) * | 1993-06-24 | 1995-08-25 | Roquette Freres | |
US5505982A (en) * | 1994-01-28 | 1996-04-09 | Fmc Corporation | Chocolate confection |
US5601858A (en) * | 1994-12-29 | 1997-02-11 | Warner-Lambert Company | Non-stick chewing gum |
US5741505A (en) | 1995-01-20 | 1998-04-21 | Mars, Incorporated | Edible products having inorganic coatings |
GB9502794D0 (en) | 1995-02-14 | 1995-04-05 | Cerestar Holding Bv | Chocolate composition |
FR2740300B1 (fr) | 1995-10-30 | 1998-01-02 | Roquette Freres | Revetement sans sucre obtenu par drageification dure et son procede d'obtention |
US5827549A (en) | 1996-02-21 | 1998-10-27 | Wm. Wrigley, Jr. Company | Process control system for automated continuous production of chewing gum |
GB9704563D0 (en) | 1997-03-05 | 1997-04-23 | Cadbury Schweppes Plc | Preparation of coated confectionery |
US6627233B1 (en) | 1997-09-18 | 2003-09-30 | Wm. Wrigley Jr. Company | Chewing gum containing physiological cooling agents |
GB9801132D0 (en) | 1998-01-21 | 1998-03-18 | Cadbury Schweppes Plc | Method and apparatus of coating articles |
BR9911287A (pt) | 1998-06-16 | 2001-03-06 | Victor R Davila | Método de produção de chocolate resistente ao calor e composições similares ao chocolate com viscosidade aparente reduzida, bem como produtos elaborados destes |
GB2339381A (en) | 1998-07-10 | 2000-01-26 | Mars Inc | Tempering chocolate with cocoa powder |
US6599542B1 (en) | 1998-08-11 | 2003-07-29 | Warner-Lambert Company | Non-stick chewing gum base |
US20020098264A1 (en) | 1998-11-27 | 2002-07-25 | Cherukuri Subraman R. | Medicated chewing gum delivery system for nicotine |
US6344222B1 (en) * | 1998-09-03 | 2002-02-05 | Jsr Llc | Medicated chewing gum delivery system for nicotine |
GB2342030A (en) * | 1998-10-01 | 2000-04-05 | Nestle Sa | Confectionery containing iota-carrageenan |
WO2000025598A1 (en) | 1998-11-03 | 2000-05-11 | Dandy A/S | Sucrose fatty acid esters for use as increased release of active ingredients |
US6531114B1 (en) * | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
CA2363060A1 (en) | 1999-01-07 | 2000-07-13 | Danisco Cultor America, Inc. | Dietetic chocolate composition |
US6833149B2 (en) | 1999-01-14 | 2004-12-21 | Cargill, Incorporated | Method and apparatus for processing vegetable oil miscella, method for conditioning a polymeric microfiltration membrane, membrane, and lecithin product |
GB9902073D0 (en) * | 1999-01-29 | 1999-03-24 | Nestle Sa | Chewy confectionery product |
US6200608B1 (en) * | 1999-03-19 | 2001-03-13 | L. A. Dreyfus Co. | Process of producing chewing gum base in particle form and product thereof |
US6322806B1 (en) * | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
US20050089600A1 (en) * | 1999-07-09 | 2005-04-28 | Reed Michael A. | Chewing gum having extended flavor duration and methods for making same |
FR2796813B3 (fr) | 1999-07-30 | 2001-12-28 | Oleagineux Ind | Ingredients composites et multifonctionnels utilises dans la fabrication de gommes de base pour gomme a macher |
US6284291B1 (en) | 1999-08-09 | 2001-09-04 | Warner-Lambert Company | Method and apparatus for continuously forming center-filled gum |
US6243014B1 (en) * | 1999-08-27 | 2001-06-05 | Micron Technology, Inc. | Electrical apparatuses, termite sensing apparatuses, and methods of forming electrical apparatuses |
WO2001049124A1 (en) | 1999-12-30 | 2001-07-12 | Wm. Wrigley Jr. Company | Release of lipophilic active agents from chewing gum |
EP1250054B1 (en) | 2000-01-27 | 2006-07-26 | Fonterra Tech Limited | Gum base |
WO2001056397A1 (en) | 2000-02-07 | 2001-08-09 | Lucia Vioara Dobroi | Chocolate composition and manufacturing procedure |
US6280780B1 (en) | 2000-08-24 | 2001-08-28 | Warner-Lambert Company | Method and apparatus for continuously forming coated center-filled gum products |
US6838098B2 (en) | 2000-09-07 | 2005-01-04 | Cadbury Adams Usa, Llc | Continuous formation of center filled gum |
US6472001B1 (en) | 2000-09-07 | 2002-10-29 | Joseph M. Bunkers | System for continuously forming center filled gum |
US6592928B2 (en) * | 2000-11-15 | 2003-07-15 | Nestec S.A. | Festooned laminated candy and methods for making same |
GB0031308D0 (en) | 2000-12-21 | 2001-01-31 | Nestle Sa | Shell-moulded fat-containing confectionery products with viscous filling |
US6558727B2 (en) | 2001-01-19 | 2003-05-06 | Warner-Lambert Company | High precision multiple-extrusion of confectionary products |
US6759079B2 (en) | 2001-01-31 | 2004-07-06 | Nestec S.A. | Shaped, center-filled confectionery products |
US20040142066A1 (en) | 2001-03-23 | 2004-07-22 | Lone Andersen | Biodegradable chewing gum and method of manufacturing such chewing gum |
JP2004524410A (ja) | 2001-03-23 | 2004-08-12 | ガムリンク エー/エス | チューインガム用の分解可能な樹脂置換体 |
EP1370154B1 (en) | 2001-03-23 | 2008-01-09 | Gumlink A/S | Degradable elastomers for chewing gum base |
CA2440040A1 (en) * | 2001-03-23 | 2002-10-03 | Gumlink A/S | One-step process for preparing chewing gum |
WO2002076231A1 (en) | 2001-03-23 | 2002-10-03 | Gumlink A/S | Biodegradable chewing gum and method of manufacturing such chewing gum |
WO2002091848A1 (en) | 2001-05-15 | 2002-11-21 | The Procter & Gamble Company | Confectionery compositions |
KR20010078976A (ko) * | 2001-05-28 | 2001-08-22 | 전창호 | 껌의 조성물 |
SE0102197D0 (sv) | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
US20030008229A1 (en) * | 2001-06-25 | 2003-01-09 | Prakash Seth | Thermally sensitive coating compositions useful for lithographic elements |
US6805890B2 (en) | 2001-09-06 | 2004-10-19 | Nestec S.A. | Laminated, extruded candy products |
CA2472592C (en) | 2002-01-15 | 2011-07-19 | Mars Incorporated | Method for chocolate coating of soft confectionery centers |
NL1020871C2 (nl) | 2002-06-14 | 2003-12-17 | Melle Technology Ct B V Van | Inrichting en werkwijze voor het tot afzonderlijke delen vormen van een streng. |
CA2491350C (en) | 2002-07-02 | 2013-03-19 | Gumlink A/S | Compressed resin moderated chewing gum |
CA2491295C (en) | 2002-07-02 | 2010-10-12 | Gumlink A/S | Compressed chewing gum |
KR100992521B1 (ko) | 2002-07-02 | 2010-11-05 | 굼링크 에이/에스 | 츄잉 검 압축 정제 ii |
EP1549153B1 (en) | 2002-09-24 | 2012-12-05 | Gumlink A/S | Chewing gum having improved release of chewing gum ingredients |
DE60234884D1 (de) | 2002-09-24 | 2010-02-04 | Gumlink As | Kaugummi mit niedrigem Feuchtigkeitsgehalt |
US20040180110A1 (en) | 2003-03-14 | 2004-09-16 | Atul Mistry | Chewing gum and confectionery compositions containing an endothermic agent |
US7409780B2 (en) * | 2003-07-21 | 2008-08-12 | Reebok International Ltd. | Bellowed chamber for a shoe |
WO2005074701A1 (en) | 2004-02-10 | 2005-08-18 | Hleks Gida Sanayi Ve Ticaret A.S. | A confection and its manufacturing method |
NL1027163C2 (nl) * | 2004-10-01 | 2006-04-04 | Cobra Beheer Bv | Steuninrichting voor een kermisattractie. |
US9565867B2 (en) | 2004-10-08 | 2017-02-14 | Gumlink A/S | Confectionery product comprising low molecular weight polyvinyl acetate |
CA2595883A1 (en) | 2005-01-28 | 2006-08-03 | Gumlink A/S | Chewing gum piece and process for making the same |
WO2006116995A1 (en) | 2005-05-04 | 2006-11-09 | Gumlink A/S | Biodegradable toffee gum |
JP4823974B2 (ja) | 2007-06-19 | 2011-11-24 | 古河電気工業株式会社 | 蓄電池の残存容量検知方法及び残存容量検知装置 |
-
2004
- 2004-10-08 US US11/664,984 patent/US9565867B2/en active Active
- 2004-10-08 WO PCT/DK2004/000691 patent/WO2006037319A1/en active Application Filing
- 2004-10-08 JP JP2007535015A patent/JP2008515407A/ja active Pending
- 2004-10-08 MX MX2007004045A patent/MX2007004045A/es active IP Right Grant
- 2004-10-08 AU AU2004323874A patent/AU2004323874A1/en not_active Withdrawn
- 2004-10-08 EP EP04762910.0A patent/EP1796482B2/en not_active Expired - Lifetime
- 2004-10-08 CA CA2581289A patent/CA2581289C/en not_active Expired - Lifetime
- 2004-10-08 CN CN2004800441742A patent/CN101039587B/zh not_active Expired - Lifetime
- 2004-10-08 ES ES04762910T patent/ES2369501T5/es not_active Expired - Lifetime
- 2004-10-08 AT AT04762910T patent/ATE515949T1/de not_active IP Right Cessation
-
2005
- 2005-05-20 KR KR1020077010371A patent/KR101279821B1/ko active IP Right Grant
- 2005-05-20 KR KR1020137002676A patent/KR20130025960A/ko not_active Application Discontinuation
- 2005-05-20 CN CN2005800342188A patent/CN101035436B/zh not_active Expired - Fee Related
- 2005-05-20 EP EP05741789.1A patent/EP1796483B1/en not_active Not-in-force
- 2005-05-20 MX MX2007004047A patent/MX2007004047A/es active IP Right Grant
- 2005-05-20 US US11/664,986 patent/US20080286409A1/en not_active Abandoned
- 2005-05-20 JP JP2007535017A patent/JP2008515408A/ja active Pending
- 2005-05-20 AU AU2005291722A patent/AU2005291722B2/en not_active Expired - Fee Related
- 2005-05-20 CA CA002581290A patent/CA2581290A1/en not_active Abandoned
- 2005-05-20 WO PCT/DK2005/000335 patent/WO2006037322A1/en active Application Filing
- 2005-05-20 RU RU2007117133A patent/RU2364244C2/ru active
- 2005-10-10 RU RU2007117134/13A patent/RU2416977C2/ru not_active IP Right Cessation
- 2005-10-10 CN CN2005800342192A patent/CN101035437B/zh active Active
- 2005-10-10 KR KR1020077010372A patent/KR101320490B1/ko not_active IP Right Cessation
- 2005-10-10 US US11/664,985 patent/US20090214698A1/en not_active Abandoned
- 2005-10-10 ES ES05790923.6T patent/ES2486848T3/es active Active
- 2005-10-10 MX MX2007004044A patent/MX2007004044A/es active IP Right Grant
- 2005-10-10 DK DK05790923.6T patent/DK1796484T3/da active
-
2012
- 2012-01-20 JP JP2012009578A patent/JP5415570B2/ja not_active Expired - Fee Related
- 2012-09-07 US US13/607,261 patent/US20130202735A1/en not_active Abandoned
-
2015
- 2015-01-12 US US14/594,909 patent/US20150122279A1/en not_active Abandoned
-
2016
- 2016-04-22 US US15/136,553 patent/US20160235086A1/en not_active Abandoned
-
2017
- 2017-01-20 US US15/411,205 patent/US10391054B2/en not_active Expired - Lifetime
- 2017-05-23 US US15/602,968 patent/US11135156B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108289469A (zh) * | 2015-12-02 | 2018-07-17 | 日清奥利友集团株式会社 | 包覆用油脂组合物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101039587A (zh) | 糖果产品 | |
CN100367869C (zh) | 压缩口香糖 | |
KR101132377B1 (ko) | 압착된 츄잉 껌 정제 | |
CN1633241A (zh) | 压缩口香糖片ii | |
JP4875616B2 (ja) | 圧縮チューインガムタブレット | |
CN1319462C (zh) | 被涂层的可降解的且具有长的储存期限的口香糖及其制造方法 | |
JP5133499B2 (ja) | 樹脂調整圧縮成形チューインガム | |
JP2008528009A (ja) | チューインガム小片及びその製造方法 | |
JP5414989B2 (ja) | 菓子製品 | |
CN1925752A (zh) | 压缩生物可降解口香糖 | |
CN101119645A (zh) | 口香糖块及其生产工艺 | |
JP2010252816A (ja) | 圧縮チューインガムタブレット | |
CN101253920B (zh) | 压缩口香糖片 | |
RU2347367C1 (ru) | Кондитерский продукт | |
KR100880203B1 (ko) | 압축 츄잉 검 | |
JP2014158484A (ja) | 圧縮チューインガムタブレット |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170112 Address after: Vejle, Denmark Patentee after: FERTIN PHARMA A/S Address before: Vejle, Denmark Patentee before: GUMLINK A/S |
|
CX01 | Expiry of patent term |
Granted publication date: 20120718 |